<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Cells</journal-id>
<journal-id journal-id-type="iso-abbrev">Cells</journal-id>
<journal-id journal-id-type="publisher-id">cells</journal-id>
<journal-title-group>
<journal-title>Cells</journal-title>
</journal-title-group>
<issn pub-type="epub">2073-4409</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31881755</article-id>
<article-id pub-id-type="pmc">7016687</article-id>
<article-id pub-id-type="doi">10.3390/cells9010062</article-id>
<article-id pub-id-type="publisher-id">cells-09-00062</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>CD38, CD157, and RAGE as Molecular Determinants for Social Behavior</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1779-0606</contrib-id>
<name>
<surname>Higashida</surname>
<given-names>Haruhiro</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
<xref ref-type="aff" rid="af2-cells-09-00062">2</xref>
<xref ref-type="corresp" rid="c1-cells-09-00062">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hashii</surname>
<given-names>Minako</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
<xref ref-type="aff" rid="af3-cells-09-00062">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tanaka</surname>
<given-names>Yukie</given-names>
</name>
<xref ref-type="aff" rid="af4-cells-09-00062">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Matsukawa</surname>
<given-names>Shigeru</given-names>
</name>
<xref ref-type="aff" rid="af5-cells-09-00062">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Higuchi</surname>
<given-names>Yoshihiro</given-names>
</name>
<xref ref-type="aff" rid="af6-cells-09-00062">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gabata</surname>
<given-names>Ryosuke</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsubomoto</surname>
<given-names>Makoto</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Seishima</surname>
<given-names>Noriko</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Teramachi</surname>
<given-names>Mitsuyo</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kamijima</surname>
<given-names>Taiki</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hattori</surname>
<given-names>Tsuyoshi</given-names>
</name>
<xref ref-type="aff" rid="af7-cells-09-00062">7</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2210-0446</contrib-id>
<name>
<surname>Hori</surname>
<given-names>Osamu</given-names>
</name>
<xref ref-type="aff" rid="af7-cells-09-00062">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tsuji</surname>
<given-names>Chiharu</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5093-3480</contrib-id>
<name>
<surname>Cherepanov</surname>
<given-names>Stanislav M.</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shabalova</surname>
<given-names>Anna A.</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gerasimenko</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Minami</surname>
<given-names>Kana</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yokoyama</surname>
<given-names>Shigeru</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Munesue</surname>
<given-names>Sei-ichi</given-names>
</name>
<xref ref-type="aff" rid="af8-cells-09-00062">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harashima</surname>
<given-names>Ai</given-names>
</name>
<xref ref-type="aff" rid="af8-cells-09-00062">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>Yasuhiko</given-names>
</name>
<xref ref-type="aff" rid="af8-cells-09-00062">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Salmina</surname>
<given-names>Alla B.</given-names>
</name>
<xref ref-type="aff" rid="af1-cells-09-00062">1</xref>
<xref ref-type="aff" rid="af2-cells-09-00062">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lopatina</surname>
<given-names>Olga</given-names>
</name>
<xref ref-type="aff" rid="af2-cells-09-00062">2</xref>
</contrib>
</contrib-group>
<aff id="af1-cells-09-00062"><label>1</label>Department of Basic Research on Social Recognition and Memory, Research Center for Child Mental Development, Kanazawa University, Kanazawa 920-8640, Japan; <email>minahashii@gmail.com</email> (M.H.); <email>rgabata@gmail.com</email> (R.G.); <email>makoto_tsubomoto@yahoo.co.jp</email> (M.T.); <email>nseishima@med.kanazawa-u.ac.jp</email> (N.S.); <email>mitsuyo.teramachi@gmail.com</email> (M.T.); <email>kamiji0029@yahoo.co.jp</email> (T.K.); <email>ctsuji@med.kanazawa-u.ac.jp</email> (C.T.); <email>stas4476@mail.ru</email> (S.M.C.); <email>ashabalova@me.com</email> (A.A.S.); <email>mgera_08@mail.ru</email> (M.G.); <email>minami-k@staff.kanazawa-u.ac.jp</email> (K.M.); <email>shigeruy@med.kanazawa-u.ac.jp</email> (S.Y.)</aff>
<aff id="af2-cells-09-00062"><label>2</label>Laboratory of Social Brain Study, Research Institute of Molecular Medicine and Pathobiochemistry, Krasnoyarsk State Medical University named after Prof. V.F. Voino-Yasenetsky, Krasnoyarsk 660022, Russia; <email>allasalmina@mail.ru</email> (A.B.S.); </aff>
<aff id="af3-cells-09-00062"><label>3</label>Division of Molecular Genetics and Clinical Research, National Hospital Organization Nanao Hospital, Nanao 926-0841, Japan</aff>
<aff id="af4-cells-09-00062"><label>4</label>Molecular Biology and Chemistry, Faculty of Medical Science, University of Fukui, Fukui 910-1193, Japan; <email>ytanaka@u-fukui.ac.jp</email></aff>
<aff id="af5-cells-09-00062"><label>5</label>Life Science Research Laboratory, University of Fukui, Fukui 910-1193, Japan; <email>ma-tsu-ka@hotmail.co.jp</email></aff>
<aff id="af6-cells-09-00062"><label>6</label>Molecular Pharmacology, Suzuka University of Medical Science, Suzuka 513-0816, Japan; <email>higuchiyjp@yahoo.co.jp</email></aff>
<aff id="af7-cells-09-00062"><label>7</label>Department of Neuroanatomy, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8640, Japan; <email>thattori@staff.kanazawa-u.ac.jp</email> (T.H.); <email>osamuh3@staff.kanazawa-u.ac.jp</email> (O.H.)</aff>
<aff id="af8-cells-09-00062"><label>8</label>Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences, Kanazawa 920-8640, Japan; <email>smunesue@med.kanazawa-u.ac.jp</email> (S.-i.M.); <email>aharashima@staff.kanazawa-u.ac.jp</email> (A.H.); <email>yasuyama@med.kanazawa-u.ac.jp</email> (Y.Y.)</aff>
<author-notes>
<corresp id="c1-cells-09-00062"><label>*</label>Correspondence: <email>haruhiro@med.kanazawa-u.ac.jp</email>; Tel.: +81-76-265-2455; Fax: +81-76-234-4213</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>12</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>1</month>
<year>2020</year>
</pub-date>
<volume>9</volume>
<issue>1</issue>
<elocation-id>62</elocation-id>
<history>
<date date-type="received">
<day>31</day>
<month>10</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>12</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>© 2019 by the authors.</copyright-statement>
<copyright-year>2019</copyright-year>
<license license-type="open-access">
<license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
</license>
</permissions>
<abstract>
<p>Recent studies provide evidence to support that cluster of differentiation 38 (CD38) and CD157 meaningfully act in the brain as neuroregulators. They primarily affect social behaviors. Social behaviors are impaired in <italic>Cd38</italic> and <italic>Cd157</italic> knockout mice. Single-nucleotide polymorphisms of the <italic>CD38</italic> and <italic>CD157/BST1</italic> genes are associated with multiple neurological and psychiatric conditions, including autism spectrum disorder, Parkinson’s disease, and schizophrenia. In addition, both antigens are related to infectious and immunoregulational processes. The most important clues to demonstrate how these molecules play a role in the brain are oxytocin (OT) and the OT system. OT is axo-dendritically secreted into the brain from OT-containing neurons and causes activation of OT receptors mainly on hypothalamic neurons. Here, we overview the CD38/CD157-dependent OT release mechanism as the initiation step for social behavior. The receptor for advanced glycation end-products (RAGE) is a newly identified molecule as an OT binding protein and serves as a transporter of OT to the brain, crossing over the blood–brain barrier, resulting in the regulation of brain OT levels. We point out new roles of CD38 and CD157 during neuronal development and aging in relation to nicotinamide adenine dinucleotide<sup>+</sup> levels in embryonic and adult nervous systems. Finally, we discuss how CD38, CD157, and RAGE are crucial for social recognition and behavior in daily life.</p>
</abstract>
<kwd-group>
<kwd>CD38</kwd>
<kwd>CD157</kwd>
<kwd>RAGE</kwd>
<kwd>NAD</kwd>
<kwd>cyclic ADP-ribose (cADPR)</kwd>
<kwd>social memory</kwd>
<kwd>oxytocin transporter</kwd>
<kwd>autism</kwd>
<kwd>anxiety</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-cells-09-00062" sec-type="intro">
<title>1. Introduction</title>
<p>Accumulating evidence indicates that immune-related molecules tend to be involved in the neuronal system. Unexpectedly a number of immune molecules were reported to possess neuronal functions [<xref ref-type="bibr" rid="B1-cells-09-00062">1</xref>]. Among them, cluster of differentiation 38 (CD38) is a transmembrane glycoprotein and has ADP-ribosyl cyclase activities and functions in cell activation on many hematopoietic, plasma, and B and T lymphocytes [<xref ref-type="bibr" rid="B2-cells-09-00062">2</xref>,<xref ref-type="bibr" rid="B3-cells-09-00062">3</xref>,<xref ref-type="bibr" rid="B4-cells-09-00062">4</xref>]. Another example is CD157, first identified as bone marrow stromal cell antigen-1 (BST-1) from rheumatoid patients [<xref ref-type="bibr" rid="B5-cells-09-00062">5</xref>,<xref ref-type="bibr" rid="B6-cells-09-00062">6</xref>,<xref ref-type="bibr" rid="B7-cells-09-00062">7</xref>]. CD157 is a glycosylphosphatidylinositol-anchored molecule that facilitates pre-B-cell growth [<xref ref-type="bibr" rid="B6-cells-09-00062">6</xref>]. The deduced amino-acid sequence of CD157 exhibits 33% similarity with CD38 [<xref ref-type="bibr" rid="B3-cells-09-00062">3</xref>,<xref ref-type="bibr" rid="B4-cells-09-00062">4</xref>].</p>
<p>The first study to report physiological functions of CD38 in the brain was published by Jin et al. in 2007, in that CD38 has an important role in oxytocin (OT) secretion in the hypothalamus and in regulating of social memory and social interactions [<xref ref-type="bibr" rid="B8-cells-09-00062">8</xref>,<xref ref-type="bibr" rid="B9-cells-09-00062">9</xref>,<xref ref-type="bibr" rid="B10-cells-09-00062">10</xref>]. The mechanism underlying the regulation of OT release from OT-containing neurons involves increases in intracellular free Ca<sup>2+</sup> concentrations by mobilization of Ca<sup>2+</sup> through ryanodine receptors type II or III [<xref ref-type="bibr" rid="B3-cells-09-00062">3</xref>,<xref ref-type="bibr" rid="B4-cells-09-00062">4</xref>,<xref ref-type="bibr" rid="B11-cells-09-00062">11</xref>,<xref ref-type="bibr" rid="B12-cells-09-00062">12</xref>] from intracellular Ca<sup>2+</sup> pools by cyclic ADP-ribose (cADPR).</p>
<p>An exciting study was reported in 2009 that genome-wide association studies (GWASs) identified single-nucleotide polymorphisms (SNPs) in the <italic>CD157/BST1</italic> gene as risk factors for Parkinson’s disease in the Japanese cohort [<xref ref-type="bibr" rid="B13-cells-09-00062">13</xref>], followed by confirmation in different populations in subsequent reports [<xref ref-type="bibr" rid="B14-cells-09-00062">14</xref>]. These human GWASs suggest some kind of roles of CD157 in the brain. However, no evidence on the neuronal role of CD157 is available for the past five years, since the discovery of the SNPs. Interestingly, the results obtained from gene deletion of <italic>Cd157</italic> mice showed merely motor dysfunction but social behavioral impairments, including apathy-, anxiety-, and depression-like behaviors [<xref ref-type="bibr" rid="B15-cells-09-00062">15</xref>,<xref ref-type="bibr" rid="B16-cells-09-00062">16</xref>]. Of course, social deficits are also important symptoms of Parkinson’s disease. These <italic>Cd157</italic> knockout (KO) mice are expected to analyze such non-motor impairments in order to improve quality of life.</p>
<p>Now, immune molecules, CD38 and CD157, are the immuno-neuronal molecules which also regulate neuronal function. Because functional roles of CD157 in the intestinal tissue were reported in 2012 [<xref ref-type="bibr" rid="B17-cells-09-00062">17</xref>], this molecule is the immuno-entero-neuronal molecule [<xref ref-type="bibr" rid="B6-cells-09-00062">6</xref>,<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>]. In this article, we mainly mention various characteristics of CD38 and CD157 in relation to brain function, behavior, and impaired behavior in KO mice which resemble the developmental disorders such as autism spectrum disorder (ASD) [<xref ref-type="bibr" rid="B10-cells-09-00062">10</xref>,<xref ref-type="bibr" rid="B12-cells-09-00062">12</xref>,<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>]. We make clear the similarity and dissimilarity between CD38 and CD157, which sheds light on future questions to be asked for the function of such molecules.</p>
</sec>
<sec id="sec2-cells-09-00062">
<title>2. Genes and Single-Nucleotide Polymorphisms</title>
<p>The <italic>CD38</italic> and <italic>CD157/BST1</italic> genes are located on the subregion of the human chromosome 4p15 as a next neighbor. The genescape is well documented [<xref ref-type="bibr" rid="B3-cells-09-00062">3</xref>,<xref ref-type="bibr" rid="B4-cells-09-00062">4</xref>,<xref ref-type="bibr" rid="B5-cells-09-00062">5</xref>,<xref ref-type="bibr" rid="B6-cells-09-00062">6</xref>,<xref ref-type="bibr" rid="B7-cells-09-00062">7</xref>,<xref ref-type="bibr" rid="B19-cells-09-00062">19</xref>,<xref ref-type="bibr" rid="B20-cells-09-00062">20</xref>,<xref ref-type="bibr" rid="B21-cells-09-00062">21</xref>].</p>
<p>For an association study of <italic>CD38</italic> and ASD, 10 intronic SNPs of <italic>CD38</italic> were examined in a case–control study in a Japanese population. No significant association with ASD was identified in these SNPs [<xref ref-type="bibr" rid="B21-cells-09-00062">21</xref>]. Furthermore, when performed in the United States (US) ASD DNA cohort (selected Caucasian 252 trios in the Autism Genetic Resource Exchange (AGRE) samples), none of the selected SNPs showed significant associations [<xref ref-type="bibr" rid="B21-cells-09-00062">21</xref>]. However, if focused only in the US high functioning autism subgroup, SNPs of 104 trios in our AGRE revealed association in rs6449197 (<italic>p</italic> = 0.040) and rs3796863 (<italic>p</italic> = 0.005). Unfortunately, no association was detected in Japanese high functioning autism trio cases (<italic>p</italic> = 0.228). With respect to one exonic SNP, rs1800561 (4693C &gt; T), some Asian ASD patients and controls possess arginine (dominant) and/or tryptophan at the 140th amino acid of CD38. Although there was no clear association in the SNP, ASD probands carrying tryptophan CD38, instead of arginine, were segregated in three Japanese families examined [<xref ref-type="bibr" rid="B21-cells-09-00062">21</xref>].</p>
<p>These initial SNPs analyzed for <italic>CD38</italic> including rs3796863 were extended to infants’ attention to social eye cues [<xref ref-type="bibr" rid="B22-cells-09-00062">22</xref>] and replicated in ASD cases [<xref ref-type="bibr" rid="B23-cells-09-00062">23</xref>,<xref ref-type="bibr" rid="B24-cells-09-00062">24</xref>,<xref ref-type="bibr" rid="B25-cells-09-00062">25</xref>,<xref ref-type="bibr" rid="B26-cells-09-00062">26</xref>,<xref ref-type="bibr" rid="B27-cells-09-00062">27</xref>,<xref ref-type="bibr" rid="B28-cells-09-00062">28</xref>]. Most recently, in association studies of <italic>CD38</italic>, meaningful association was found in anorexia nervosa [<xref ref-type="bibr" rid="B29-cells-09-00062">29</xref>] and in suicidal ideation [<xref ref-type="bibr" rid="B26-cells-09-00062">26</xref>,<xref ref-type="bibr" rid="B30-cells-09-00062">30</xref>].</p>
<p>GWASs and meta-analyses for Parkinson’s disease identified intronic SNPs in the <italic>CD157/BST1</italic> gene as new susceptibility loci in Asian and European populations [<xref ref-type="bibr" rid="B13-cells-09-00062">13</xref>,<xref ref-type="bibr" rid="B14-cells-09-00062">14</xref>,<xref ref-type="bibr" rid="B31-cells-09-00062">31</xref>]. However, it was pointed out that environmental factors may also contribute to the real pathogenic role of <italic>CD157</italic> SNPs in Parkinson’s disease [<xref ref-type="bibr" rid="B32-cells-09-00062">32</xref>].</p>
<p>Yokoyama et al. found associations between ASD and three SNPs of <italic>CD157</italic> (rs4301112, rs28532698, and rs10001565) [<xref ref-type="bibr" rid="B33-cells-09-00062">33</xref>]. These three SNPs have chromosomal locations (from chr4:15717226 to chr14:15722573) un-identical to those associated with the region in Parkinson’s disease (chr14:15725766 to chr4:15737937) [<xref ref-type="bibr" rid="B13-cells-09-00062">13</xref>,<xref ref-type="bibr" rid="B14-cells-09-00062">14</xref>]. These studies revealed that some SNPs in <italic>CD157</italic> may be risk factors for both ASD and Parkinson’s disease and those in <italic>CD38</italic> may be risk factors for several psychiatric disorders.</p>
</sec>
<sec id="sec3-cells-09-00062">
<title>3. Messenger RNA (mRNA) Expression Patterns during Development</title>
<p>The rodent brain <italic>Cd38</italic> mRNA levels sharply increased on postnatal days 7–14. In rats, the level reached a 100-fold increase in adult and, in mice, a 25-fold increase was seen from no or little level at embryo or neonates [<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>,<xref ref-type="bibr" rid="B34-cells-09-00062">34</xref>]. In contrast, the time course of <italic>Cd157</italic> mRNA is opposite to that of <italic>Cd38.</italic> The brain <italic>Cd157</italic> mRNA levels decreased 7–14 days postnatally from the relatively higher levels in the embryonic days [<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>]. However, such a relationship is yet to be studied in humans. <italic>Cd38</italic> mRNA was expressed in the four mouse brain sub-regions (hypothalamus, cerebellum, striatum, and cerebrum) [<xref ref-type="bibr" rid="B9-cells-09-00062">9</xref>], with the highest density in the hypothalamus (Supplementary Figure 11 of Jin et al. [<xref ref-type="bibr" rid="B9-cells-09-00062">9</xref>]).</p>
<p>The levels of <italic>Cd157</italic> mRNA expression in the brain regions in adult male C57BL/6 mice were very low [<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>]. These mRNA expression studies showed the quite distinct expression profiles of <italic>Cd38</italic> and <italic>Cd157</italic>.</p>
</sec>
<sec id="sec4-cells-09-00062">
<title>4. Proteins in the Brain</title>
<p>The high level of mRNA of <italic>CD38</italic> expression was measured in the human hypothalamus [<xref ref-type="bibr" rid="B21-cells-09-00062">21</xref>]. CD38 immunoreactivity was detected in many cells in the paraventricular nucleus of the hypothalamus, while much lower CD38 expression levels were observed in the insular cortex [<xref ref-type="bibr" rid="B21-cells-09-00062">21</xref>]. While there was co-expression of OT and CD38 in the hypothalamic paraventricular nucleus (PVN), there was little or no detectable OT in other parts of the cortex.</p>
<p>There were a number of studies reporting CD38 expression in glial cells, including astrocytes, microglia, and neurons [<xref ref-type="bibr" rid="B35-cells-09-00062">35</xref>,<xref ref-type="bibr" rid="B36-cells-09-00062">36</xref>,<xref ref-type="bibr" rid="B37-cells-09-00062">37</xref>,<xref ref-type="bibr" rid="B38-cells-09-00062">38</xref>,<xref ref-type="bibr" rid="B39-cells-09-00062">39</xref>,<xref ref-type="bibr" rid="B40-cells-09-00062">40</xref>,<xref ref-type="bibr" rid="B41-cells-09-00062">41</xref>,<xref ref-type="bibr" rid="B42-cells-09-00062">42</xref>,<xref ref-type="bibr" rid="B43-cells-09-00062">43</xref>]. Yamada et al. [<xref ref-type="bibr" rid="B40-cells-09-00062">40</xref>] reported by using ultrastructural analysis that CD38 immunoreactivity was detected in a subset of pyramidal neurons and astrocytes, but not in microglia or oligodendrocytes under physiological conditions in rat. Neuron–glia crosstalk also showed that astrocytes increased CD38 expression after the glutamate release from neurons [<xref ref-type="bibr" rid="B44-cells-09-00062">44</xref>]. In brain ischemia, CD38 would be predominantly expected in astrocytes to support neuronal survival by transferring extracellular mitochondria from astrocytes to neurons [<xref ref-type="bibr" rid="B45-cells-09-00062">45</xref>].</p>
<p>Furthermore, Hattori et al. [<xref ref-type="bibr" rid="B38-cells-09-00062">38</xref>] demonstrated that CD38 is already expressed in the developing brain between postnatal day 14 and day 28. In situ hybridization and flow cytometrical analysis revealed that CD38 is expressed in astrocytes at these times [<xref ref-type="bibr" rid="B38-cells-09-00062">38</xref>]. In association with this, astrocytic development is delayed in <italic>Cd38</italic> KO mice; subsequently delayed differentiation of oligodendrocytes at postnatal periods was obvious, which was replicated in the culture system. It is reasonable to conclude that astrocytic CD38 regulates the development of astrocytes in a cell-autonomous way and the differentiation of oligodendrocytes in a non-cell-autonomous manner [<xref ref-type="bibr" rid="B39-cells-09-00062">39</xref>]. Further to this, connexin43 in astrocytes plays a promotive role for CD38-mediated oligodendrocyte differentiation. Finally, increased levels of nicotinamide adenine dinucleotide<sup>+</sup> (NAD<sup>+</sup>), caused by <italic>CD38</italic> gene deficiency, suppressed astrocytic connexin43 expression and oligodendrocyte differentiation. CD38 is a positive regulator of astrocyte and oligodendrocyte development [<xref ref-type="bibr" rid="B39-cells-09-00062">39</xref>].</p>
<p>CD38 expression was reported in glial cells, such as astrocytes and microglia [<xref ref-type="bibr" rid="B37-cells-09-00062">37</xref>,<xref ref-type="bibr" rid="B40-cells-09-00062">40</xref>]. Astrocytic CD38 may regulate the maturation of astrocytes and/or differentiation of oligodendrocyte precursor cells into oligodendrocytes by metabolizing NAD<sup>+</sup> in the brain in physiological conditions [<xref ref-type="bibr" rid="B38-cells-09-00062">38</xref>].</p>
<p>In pathological conditions, CD38 seems to be involved in the activation of microglia and astrocytes in mouse models of glioma or traumatic brain injury, and human immunodeficiency virus (HIV)-infected brains [<xref ref-type="bibr" rid="B46-cells-09-00062">46</xref>,<xref ref-type="bibr" rid="B47-cells-09-00062">47</xref>,<xref ref-type="bibr" rid="B48-cells-09-00062">48</xref>]. The role of CD38 in demyelination was recently studied in cuprizone-induced demyelination in mice, which is evident by oligodendrocyte-specific apoptosis, followed by intensive glial activation, demyelination, and repopulation of oligodendrocytes [<xref ref-type="bibr" rid="B39-cells-09-00062">39</xref>]. CD38 was upregulated in astrocytes and microglia after cuprizone application. <italic>CD38</italic> deficiency did not affect the initial decrease of the number of oligodendrocytes, while it attenuated cuprizone-induced demyelination and neurodegeneration [<xref ref-type="bibr" rid="B39-cells-09-00062">39</xref>]. The clearance of the degraded myelin and oligodendrocyte repopulation could be reduced in <italic>Cd38</italic> KO mice. This was associated with reduced levels of glial activation and inflammatory responses, such as phagocytosis through the increased level of NAD<sup>+</sup> in CD38-deleted conditions. CD38 and NAD<sup>+</sup> in the glial cells may play an important role in the demyelination and subsequent oligodendrocyte remodeling by the modified glial activity and neuroinflammation.</p>
</sec>
<sec id="sec5-cells-09-00062">
<title>5. Immunohistochemistry of CD157 in Neural Stem Cells</title>
<p>Immunofluorescence images of CD157 were seen in the E17 embryo hypothalamus [<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>]. CD157 staining was seen in the cytoplasm or at the cell surface of a subset of Nestin-positive cells in the ventricular and subventricular zones near the third ventricle (<xref ref-type="fig" rid="cells-09-00062-f001">Figure 1</xref>). However, this colocalization seems to be limited to the embryonic stem cells in the mouse. The question remains as to whether or not CD157 is present in adult mouse brain stem cells.</p>
<p>Recently, Wu et al. showed that CD157 is expressed in CD45<sup>–</sup>, CD54<sup>+</sup>, CD157<sup>+</sup> lung stem/progenitor cells [<xref ref-type="bibr" rid="B49-cells-09-00062">49</xref>]. Yilmaz et al. showed that fasting in mice results in activating the mammalian target of rapamycin1 (mTOR1) pathway and induction of CD157 in Paneth cells in the adult intestine [<xref ref-type="bibr" rid="B17-cells-09-00062">17</xref>,<xref ref-type="bibr" rid="B50-cells-09-00062">50</xref>]. cADPR produced by CD157 can inhibit the differentiation of intestinal stem cells into acinar cells, thus facilitating self-renewal of intestinal stem cells [<xref ref-type="bibr" rid="B17-cells-09-00062">17</xref>]. These results suggest that CD157 functions in stem cells in two other organs.</p>
<p>Very recently, CD157 was discovered in an endothelial stem cell population required for vascular regeneration and tissue maintenance [<xref ref-type="bibr" rid="B51-cells-09-00062">51</xref>], as well as in the mammary gland [<xref ref-type="bibr" rid="B52-cells-09-00062">52</xref>]. cADPR may function in these stem cells, as shown in Paneth cells [<xref ref-type="bibr" rid="B17-cells-09-00062">17</xref>]. In the nervous system, however, CD157 plays a role in neuronal migration during neural stem cell growth and neurogenesis. It was indicated that CD157 binds to members of the integrin family [<xref ref-type="bibr" rid="B53-cells-09-00062">53</xref>,<xref ref-type="bibr" rid="B54-cells-09-00062">54</xref>]. Therefore, it would be interesting to examine whether cADPR facilitates the self-renewal of stem cells and forms a complex of CD157 and integrin.</p>
<p>In addition, it was found that CD157 is resident of endothelial cells and a hallmark [<xref ref-type="bibr" rid="B51-cells-09-00062">51</xref>,<xref ref-type="bibr" rid="B55-cells-09-00062">55</xref>]. CD157<sup>+</sup>, CD200<sup>+</sup> endothelial cells play a role in a stem cell population with self-renewal capacity as determined blood vessels. Such endothelial stem cells can differentiate into CD157<sup>−</sup>, CD200<sup>−</sup> endothelial cells through CD157<sup>+</sup>, CD200<sup>−</sup> (progenitor) cells [<xref ref-type="bibr" rid="B55-cells-09-00062">55</xref>]. Thus, it is interesting to find such markers in neural stem cell development.</p>
</sec>
<sec id="sec6-cells-09-00062">
<title>6. Binding of CD38 to Calcium Calmodulin-Dependent Kinase</title>
<p>CD38 produces Ca<sup>2+</sup>-mobilizing second messengers via its catalytic site [<xref ref-type="bibr" rid="B3-cells-09-00062">3</xref>]. With respect to molecular mechanisms of enzyme activity modulation, we recently detected CD38-interacting proteins by proteomic analysis using two-dimensional gel electrophoresis followed by mass spectrometry [<xref ref-type="bibr" rid="B56-cells-09-00062">56</xref>]. We identified the β-isoform of Ca<sup>2+</sup>-calmodulin-dependent protein kinase II (CAMKII) as the human CD38 (hCD38)-binding protein from HEK-293 cells overexpressing hCD38 (<xref ref-type="fig" rid="cells-09-00062-f002">Figure 2</xref>).</p>
<p>Pharmacological methods confirmed the functional interaction of CAMKIIβ and CD38 [<xref ref-type="bibr" rid="B56-cells-09-00062">56</xref>]. Briefly, in <italic>human influenza hemagglutinin</italic> (<italic>HA)-CD38</italic> complementary DNA (cDNA)-transfected human embryonic kidney (HEK) culture cells, the wound open space surrounded with a healing border became small after 24 h. The transfected cells treated with an inhibitor of CAMKII, KN-62, did not close the open space without wound healing (<xref ref-type="fig" rid="cells-09-00062-f003">Figure 3</xref>). Quantitatively, <italic>CD38</italic> cDNA-transfected samples treated with KN-62 had significantly less migratory activity compared with those without KN, suggesting a possible interaction between CD38 and CAMKII.</p>
<p>For the point of targets, CAMKII activated by increased cytosolic Ca<sup>2+</sup> functions as a multifunctional serine/threonine kinase to activate downstream signaling pathways [<xref ref-type="bibr" rid="B57-cells-09-00062">57</xref>], such as the activation of ryanodine receptors by phosphorylation [<xref ref-type="bibr" rid="B58-cells-09-00062">58</xref>]. Another candidate target of activated CAMKII is actin dynamics. The cytoskeleton protein actin (F-actin) binds to CAMKII [<xref ref-type="bibr" rid="B59-cells-09-00062">59</xref>], and this binding is specific to the β-isoform [<xref ref-type="bibr" rid="B57-cells-09-00062">57</xref>]. It was shown that CaMKIIβ binds to monomeric actin to reduce actin polymerization. When Ca<sup>2+</sup> binds to CaMKIIβ, the CaMKIIβ–actin interaction is antagonized, and actin polymerization is facilitated [<xref ref-type="bibr" rid="B60-cells-09-00062">60</xref>]. Therefore, one possibility may be that CAMKIIβ and CD38 co-operate for regulation of actin dynamics characterized by such polymerization–depolymerization reactions. The efficient activation of CAMKIIβ by bound CD38 causes release of monomeric actin sequestration and facilitates actin polymerization, thereby facilitating cell migration, because the migration process requires actin polymerization [<xref ref-type="bibr" rid="B61-cells-09-00062">61</xref>]. In addition, one observation that CD38 proteins are associated with actin [<xref ref-type="bibr" rid="B62-cells-09-00062">62</xref>] supports the above idea of CD38-dependent modulation of actin dynamics.</p>
<p>The molecular weight of CD38 bound to CAMKIIβ in HEK cells is lower than that of glycosylated CD38 [<xref ref-type="bibr" rid="B56-cells-09-00062">56</xref>]. It was reported that type III CD38 is not usually glycosylated [<xref ref-type="bibr" rid="B63-cells-09-00062">63</xref>]. This leads to speculation of the possibility that type III CD38 and CAMKIIβ form a complex, rather than the type II CD38, as schematized in <xref ref-type="fig" rid="cells-09-00062-f004">Figure 4</xref>. Physically coupled CD38 and CAMKII may functionally activate downstream cellular signals efficiently, as demonstrated above in cell motility. Most recently, it was revealed that the type III CD38 interacts with integrin binding protein 1 [<xref ref-type="bibr" rid="B64-cells-09-00062">64</xref>] or transferrin, CD71 [<xref ref-type="bibr" rid="B65-cells-09-00062">65</xref>].</p>
</sec>
<sec id="sec7-cells-09-00062">
<title>7. Enzymatic Activities of CD38 and CD157</title>
<p>It was established that CD38 and CD157 belong to an ADP-ribosyl cyclase family, which elicits the formation of cADPR and/or ADP-ribose from β-NAD<sup>+</sup> [<xref ref-type="bibr" rid="B3-cells-09-00062">3</xref>,<xref ref-type="bibr" rid="B4-cells-09-00062">4</xref>,<xref ref-type="bibr" rid="B5-cells-09-00062">5</xref>,<xref ref-type="bibr" rid="B6-cells-09-00062">6</xref>,<xref ref-type="bibr" rid="B7-cells-09-00062">7</xref>,<xref ref-type="bibr" rid="B9-cells-09-00062">9</xref>,<xref ref-type="bibr" rid="B17-cells-09-00062">17</xref>,<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>,<xref ref-type="bibr" rid="B38-cells-09-00062">38</xref>]. The ADP-ribosyl cyclase activity of CD157 is much weaker than that of CD38 [<xref ref-type="bibr" rid="B3-cells-09-00062">3</xref>,<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>]. The product of base exchange is nicotinic acid adenine dinucleotide phosphate (NAADP) [<xref ref-type="bibr" rid="B3-cells-09-00062">3</xref>,<xref ref-type="bibr" rid="B66-cells-09-00062">66</xref>,<xref ref-type="bibr" rid="B67-cells-09-00062">67</xref>]. NAADP also has Ca<sup>2+</sup> mobilization activity from different Ca<sup>2+</sup> pools [<xref ref-type="bibr" rid="B6-cells-09-00062">6</xref>]. Kim and his colleagues examined whether CD157 has base exchange activity, through independently transfecting with mouse <italic>Cd157</italic> or <italic>Cd38</italic> genes, in which both proteins were well expressed [<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>]. Firstly, the ADP-ribosyl cyclase activity of <italic>Cd157</italic>-transfected HEK cells was lower than that of <italic>Cd38</italic>-transfected HEK cells. <italic>Cd157</italic>-transformed cells showed no or little NAADP synthetic activity, with no discernable differences from mock-transfected cells, suggesting that CD157 has little or no base exchange activity. In sharp contrast, <italic>Cd38</italic>-transfected HEK cells displayed higher NAADP synthetic activity compared to control cells [<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>], suggesting that the functional role of CD157 likely stems from the production of cADPR rather than NAADP. However, a question still remains whether CD157 in the nervous system mediates its functions in stem cells through cADPR but not NAADP. To consider this, the crucial role of both cADPR and CD157 in intestinal Paneth cells will give us a hint [<xref ref-type="bibr" rid="B17-cells-09-00062">17</xref>].</p>
</sec>
<sec id="sec8-cells-09-00062">
<title>8. Contribution of TRPM2 on Ca Signaling</title>
<p>It was reported that NAD<sup>+</sup> metabolites target several ion channels, including transient receptor potential melastatin 2 (TRPM2), which is a member of the warmth-sensing family that plays an important role in thermoregulation [<xref ref-type="bibr" rid="B68-cells-09-00062">68</xref>,<xref ref-type="bibr" rid="B69-cells-09-00062">69</xref>]. Activation of TRPM2 non-specific cation channels results in Ca<sup>2+</sup> influx in response to the temperature range from 34 to 40 °C [<xref ref-type="bibr" rid="B68-cells-09-00062">68</xref>]. Therefore, initially, we thought that OT release could be facilitated by activation of TRPM2 channels. Extracellular application of 100 μM cADPR increases intracellular free calcium concentrations, together with simultaneous temperature elevation by 2 °C from 35 °C in the presence of extracellular Ca<sup>2+</sup> in a single cultured cell of the anterior hypothalamus of the mouse [<xref ref-type="bibr" rid="B36-cells-09-00062">36</xref>]. Its temperature sensitivity resembles that of TRPM2 channels as a warm sensor, in that Ca<sup>2+</sup> influx through TRPM2 occurs at temperatures of the body temperature range from 34 °C to 39 °C [<xref ref-type="bibr" rid="B68-cells-09-00062">68</xref>,<xref ref-type="bibr" rid="B69-cells-09-00062">69</xref>].</p>
<p>On the contrary, β-NAD<sup>+</sup> showed a constant effect during the sustained phases required for conversion of β-NAD<sup>+</sup> to cADPR; thus, its effect seems to be identical to cADPR in the late phase. The initial free intracellular Ca<sup>2+</sup> concentration rise is more sensitive to Ca<sup>2+</sup> influx due to thermal stimulation, while ADPR and the late sustained phase are dependent on cADPR-involved Ca<sup>2+</sup> mobilization from the ryanodine-sensitive Ca<sup>2+</sup> pool. Very recently, an endogenous cADPR analogue, 2′-deoxyadenosine 5′-diphosphoribose, was documented and demonstrated to be very powerful [<xref ref-type="bibr" rid="B70-cells-09-00062">70</xref>]. It is of interest to test it in OT release in the hypothalamus.</p>
<p>Incubation with 100 μM cADPR alone induced minor increases in concentrations of OT in the culture medium of a single hypothalamus from the group-housed wild-type mice, but the OT concentration increased with additional thermal stimulation. These transient and accumulated responses with heat and cADPR suggest that heat and cADPR have distinct effects on OT release. Further confirmation was that the cADPR- and heat-induced OT concentration increase was not observed in <italic>Cd38</italic> KO mice. Overall, the results suggest that the cADPR- and heat-induced release of OT depends on CD38 and TRPM2. They provoke cADPR-producing enzyme activity and Ca<sup>2+</sup> influx through cation channels in the mouse hypothalamus that experienced social stress during group-housing [<xref ref-type="bibr" rid="B36-cells-09-00062">36</xref>,<xref ref-type="bibr" rid="B71-cells-09-00062">71</xref>]. Thus, these KO experiments revealed that both CD38 and TRPM2 are involved in the cADPR- and heat-induced facilitation of OT release in vivo. Furthermore, now, cooperative roles of TRPM2 and CD38 were reported in natural killer cells [<xref ref-type="bibr" rid="B72-cells-09-00062">72</xref>], mesenchymal stem cells [<xref ref-type="bibr" rid="B73-cells-09-00062">73</xref>], pancreatic beta cells [<xref ref-type="bibr" rid="B74-cells-09-00062">74</xref>], neutrophil granulocytes [<xref ref-type="bibr" rid="B75-cells-09-00062">75</xref>], and inflammatory monocytes [<xref ref-type="bibr" rid="B76-cells-09-00062">76</xref>]</p>
</sec>
<sec id="sec9-cells-09-00062">
<title>9. Social Behavior in Knockout Mice</title>
<p>Severe anxiety-like and depression-related behaviors are displayed in <italic>Cd157</italic> KO male mice in the light–dark transition test, known as a standard anxiety-related behavioral test [<xref ref-type="bibr" rid="B16-cells-09-00062">16</xref>,<xref ref-type="bibr" rid="B77-cells-09-00062">77</xref>,<xref ref-type="bibr" rid="B78-cells-09-00062">78</xref>]. The transition from a light to a dark arena was shorter in the <italic>Cd157</italic> KO mice, compared with the controls. However, the same test should be performed even in <italic>Cd38</italic> KO mice. While the entry frequency was different, probably because of the different genetic backgrounds of the two strains, no identical behavioral differences were found between <italic>Cd38</italic> KO and wild-type ICR mice [<xref ref-type="bibr" rid="B79-cells-09-00062">79</xref>]. These findings suggest that anxiety induced by novel environment is a distinct feature of <italic>Cd157</italic> KO mice, but not <italic>Cd38</italic> KO mice, or recently used receptor for advanced glycation end-products (<italic>RAGE</italic>) KO mice [<xref ref-type="bibr" rid="B16-cells-09-00062">16</xref>,<xref ref-type="bibr" rid="B71-cells-09-00062">71</xref>,<xref ref-type="bibr" rid="B77-cells-09-00062">77</xref>,<xref ref-type="bibr" rid="B80-cells-09-00062">80</xref>,<xref ref-type="bibr" rid="B81-cells-09-00062">81</xref>] (<xref ref-type="fig" rid="cells-09-00062-f005">Figure 5</xref>).</p>
<p>In the open field test, the time spent in the inside zone was shorter for <italic>Cd157</italic> KO mice than wild-type controls. Interestingly, this phenotype seemed to be recovered by a single intraperitoneal administration of OT with duration in the inside zone and immobility time increasing significantly [<xref ref-type="bibr" rid="B78-cells-09-00062">78</xref>].</p>
<p><italic>Cd157</italic> KO mice showed depression-like behaviors in the forced swimming and tail suspension tests [<xref ref-type="bibr" rid="B16-cells-09-00062">16</xref>]. Anxiety-like behaviors were evident in the light–dark transition test and in the elevated plus maze test. Such impaired social behaviors in the social preference test in part seem to resemble psychiatric symptoms [<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>].</p>
</sec>
<sec id="sec10-cells-09-00062">
<title>10. Differential Roles of CD38 and CD157 in Social Behavior</title>
<p>The role of <italic>CD38</italic> in OT secretion into the brain is already established [<xref ref-type="bibr" rid="B9-cells-09-00062">9</xref>,<xref ref-type="bibr" rid="B10-cells-09-00062">10</xref>,<xref ref-type="bibr" rid="B11-cells-09-00062">11</xref>,<xref ref-type="bibr" rid="B21-cells-09-00062">21</xref>,<xref ref-type="bibr" rid="B22-cells-09-00062">22</xref>]. CD38 mediates multiple reactions such as ADPR and cADPR production, TRMP2 and extracellular signal-regulated kinase (ERK1/2) activation, Ca<sup>2+</sup>-mobilization, and OT release [<xref ref-type="bibr" rid="B68-cells-09-00062">68</xref>]. Additionally, CD38 acts in OT release by activating molecular cascades of OT autoregulation [<xref ref-type="bibr" rid="B9-cells-09-00062">9</xref>,<xref ref-type="bibr" rid="B10-cells-09-00062">10</xref>]. In contrast, CD157 can bind with the serotonin transporter and integrin-β3 and invoke multiple circuits to control anxiety- and depression-like behaviors [<xref ref-type="bibr" rid="B16-cells-09-00062">16</xref>,<xref ref-type="bibr" rid="B53-cells-09-00062">53</xref>,<xref ref-type="bibr" rid="B54-cells-09-00062">54</xref>]. CD157 may play a role in cADPR-induced OT release, which is not completely clear yet (<xref ref-type="fig" rid="cells-09-00062-f005">Figure 5</xref>). The deficiency of CD157 subsequently leads to aberrant behaviors, such as increased anxiety. A decrease in volume of the amygdala [<xref ref-type="bibr" rid="B16-cells-09-00062">16</xref>], a key constituent of the social brain, might be generated by a loss of CD157 in the neural stem cells during the embryonic developmental days. This question should be further studied.</p>
</sec>
<sec id="sec11-cells-09-00062">
<title>11. Autism Spectrum Disorder</title>
<p>Hyperthermia is known to be induced by social stress [<xref ref-type="bibr" rid="B71-cells-09-00062">71</xref>,<xref ref-type="bibr" rid="B82-cells-09-00062">82</xref>,<xref ref-type="bibr" rid="B83-cells-09-00062">83</xref>,<xref ref-type="bibr" rid="B84-cells-09-00062">84</xref>]. The social stress condition induces a much more stressful effect on a subset of mice subordinate in social status than dominant in social hierarchy. Thus, in the subordinate mouse group, the release of more OT allowed them to recover from stress, which resulted in becoming tolerant to greater stress. When more stress was experienced, more OT could be released subsequently to achieve a balance, which is very medically congruent [<xref ref-type="bibr" rid="B85-cells-09-00062">85</xref>] (<xref ref-type="fig" rid="cells-09-00062-f005">Figure 5</xref>).</p>
<p>There are several unique studies of fever in ASD patients. Some ASD children exhibit amelioration in their characteristic ASD behaviors during febrile incidents. Possibly, the regression of fever may be associated with the onset of ASD [<xref ref-type="bibr" rid="B86-cells-09-00062">86</xref>,<xref ref-type="bibr" rid="B87-cells-09-00062">87</xref>]. Febrigenesis and the behavioral state changes associated with fever in ASD depend on the selective normalization [<xref ref-type="bibr" rid="B87-cells-09-00062">87</xref>]. Fever may enhance the release of OT, which can subsequently reduce abnormal ASD behavior, because external or nasal administration of OT was proven to improve aberrant behavior in rodents and humans [<xref ref-type="bibr" rid="B9-cells-09-00062">9</xref>,<xref ref-type="bibr" rid="B87-cells-09-00062">87</xref>,<xref ref-type="bibr" rid="B88-cells-09-00062">88</xref>] (<xref ref-type="fig" rid="cells-09-00062-f005">Figure 5</xref>).</p>
<p>The behavioral impairments in <italic>Cd157</italic> KO mice were recovered by OT, probably because OT directly targets the intracellular signaling networks in the social brain related to CD157, independently differing from CD38 [<xref ref-type="bibr" rid="B71-cells-09-00062">71</xref>]. This suggests that OT can be used in future for the treatment of social withdrawal in psychiatric disorders. Whether we can extend the results observed in the mouse to human behavioral recuperation is of interest, especially since there are reports regarding the effectiveness of OT for impaired social interaction as a core symptom of ASD [<xref ref-type="bibr" rid="B89-cells-09-00062">89</xref>,<xref ref-type="bibr" rid="B90-cells-09-00062">90</xref>,<xref ref-type="bibr" rid="B91-cells-09-00062">91</xref>,<xref ref-type="bibr" rid="B92-cells-09-00062">92</xref>,<xref ref-type="bibr" rid="B93-cells-09-00062">93</xref>].</p>
<p>The report by Zhong et al. [<xref ref-type="bibr" rid="B36-cells-09-00062">36</xref>] presented a new neuroendocrinological concept that fever may increase the release of OT to reduce abnormal autistic behavior. The reason for this is that external administration of OT would improve aberrant behavior in rodents and in humans (<xref ref-type="fig" rid="cells-09-00062-f005">Figure 5</xref> and <xref ref-type="fig" rid="cells-09-00062-f006">Figure 6</xref>).</p>
<p>Exogenous OT in humans induces behavioral effects, particularly in social deficit-related psychiatric disorders such as ASD [<xref ref-type="bibr" rid="B8-cells-09-00062">8</xref>,<xref ref-type="bibr" rid="B10-cells-09-00062">10</xref>,<xref ref-type="bibr" rid="B12-cells-09-00062">12</xref>,<xref ref-type="bibr" rid="B94-cells-09-00062">94</xref>]. Several clinical trials reported the neuropharmacological effects of peripherally administered OT in a variety of conditions. The potential for peripherally administered OT to act centrally is supported by measures of OT in the brain of wild-type and <italic>RAGE</italic> KO mice or OT in the adluminal side transferred from the luminal side of the cultured blood–brain barrier (BBB) [<xref ref-type="bibr" rid="B80-cells-09-00062">80</xref>] (<xref ref-type="fig" rid="cells-09-00062-f006">Figure 6</xref>). It was revealed that RAGE is required for transport of OT at the brain [<xref ref-type="bibr" rid="B80-cells-09-00062">80</xref>] and intestine [<xref ref-type="bibr" rid="B94-cells-09-00062">94</xref>], confirming that peripheral administration of OT may be useful in treatment of ASD or other psychiatry patients.</p>
</sec>
<sec id="sec12-cells-09-00062" sec-type="conclusions">
<title>12. Conclusions and Perspective</title>
<p>The present review showed several neuronal roles for CD38 and CD157, in addition to their known functions in the digestive and immune systems. These two antigens are related to the neurodevelopment of neurons, astrocytes, and oligodendrocytes, and their impairment leads to multiple neurological and psychiatric conditions, such as ASD, schizophrenia, anorexia nervosa, suicidal ideation, and Parkinson’s disease. One core symptom of such diseases involves social impairments, some of which were replicated at the mouse level, in <italic>Cd38</italic> KO and/or <italic>Cd157</italic> KO mice, as useful animal models. CD38 and/or CD157 can be referred to as a neuro-entero-immunological regulator [<xref ref-type="bibr" rid="B6-cells-09-00062">6</xref>,<xref ref-type="bibr" rid="B18-cells-09-00062">18</xref>]. Interestingly, even for CD38, it is reported that the specific SNP (rs3796863) of <italic>CD38</italic> was originally documented as an association with ASD [<xref ref-type="bibr" rid="B21-cells-09-00062">21</xref>], with close relation to gastrointestinal dysfunction, one of the typical symptoms of ASD [<xref ref-type="bibr" rid="B95-cells-09-00062">95</xref>].</p>
<p>The low expression of CD38 in the embryonic brain raises questions associated with the early onset of ASD. In sharp contrast, the low level of CD157 expression in the adult brain raises another uncertainty in the late onset of Parkinson’s disease. Thus, future questions remaining involve how CD38 and CD157 play their roles in the embryonic or aging brain. Alternatively, we would like to know the more precise neurodysregulation by impaired CD38 and CD157 in the processes of neuronal development and neurodegeneration, which results in psychiatric disorders, such as ASD, schizophrenia and Alzheimer’s disease.</p>
<p>A recent topic is the cellular location of CD38 and association proteins, such as CAMKII, as shown in this article. Lee and Shao discovered other associated molecules or restricted amino acids in CD38 which can guide them to the topologically correct position as type II or type III glycoproteins [<xref ref-type="bibr" rid="B96-cells-09-00062">96</xref>]. In addition, it was found that sterile alpha and Toll/interleukin-1 receptor motif-containing 1 (SARM1), which is located in neuronal mitochondria and is activated by nicotinamide mononucleotide, displays enzymatic ability to form cADPR and ADPR from NAD<sup>+</sup> [<xref ref-type="bibr" rid="B96-cells-09-00062">96</xref>,<xref ref-type="bibr" rid="B97-cells-09-00062">97</xref>], which is nearly identical to the enzyme activity of CD38. However, comparing cADPR for the OT release mechanism, it is considered to induce cell death (degeneration) in cortical neurons and axons [<xref ref-type="bibr" rid="B98-cells-09-00062">98</xref>,<xref ref-type="bibr" rid="B99-cells-09-00062">99</xref>], which is a pathophysiological aspect. This NAD<sup>+</sup>-related field will be studied intensively in near future.</p>
<p>Finally, the discovery of the OT-binding and transporter protein, RAGE [<xref ref-type="bibr" rid="B80-cells-09-00062">80</xref>,<xref ref-type="bibr" rid="B94-cells-09-00062">94</xref>], will bridge novel functional roles in the peripheral and central presence of OT. For more than 100 years since the discovery of OT, it is firmly thought that peripheral OT does not go into the brain, except for its information which is transmitted by the ascending sensory nerve. The discovery of the OT transporter not only contributes to solving the enigma of OT in clinical trials for ASD patients, but also adds a new concept for the brain function of this important hormone in social behavior.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>We thank Teruko Yuhi and Kazumi Furuhara for technical assistance.</p>
</ack>
<notes>
<title>Author Contributions</title>
<p>H.H. conceptualized and wrote the manuscript. M.H., Y.T., S.M. (Shigeru Matsukawa), Y.H., R.G., M.T., N.I., M.T., T.K., and S.Y. studied on CaMKII. T.H. and O.H. worked on glial cells. C.T., S.M.C., A.A.S., M.G., and K.M. investigated <italic>Cd157</italic> and <italic>Cd38</italic> KO mice. S.M. (Sei-ichi Munesue), A.H., Y.Y., A.B.S., and O.L. were involved with RAGE. O.L. drew figures and calculated statistics. All authors have read and agreed to the published version of the manuscript.</p>
</notes>
<notes>
<title>Funding</title>
<p>We acknowledge financial support from the Kanazawa University SAKIGAKE project 2018 and 2019 and the Strategic Research Program for Brain Sciences from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. We thank the Grants-in-Aid for Scientific Research (24590375, 25461335, and 18K06889) and the Program for Fostering Globally Talented Researchers from the Japan Society for Promotion of Sciences.</p>
</notes>
<notes notes-type="COI-statement">
<title>Conflicts of Interest</title>
<p>The authors declare no conflicts of interest.</p>
</notes>
<ref-list>
<title>References</title>
<ref id="B1-cells-09-00062">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thielens</surname>
<given-names>N.M.</given-names>
</name>
<name>
<surname>Tedesco</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bohlsn</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Gaboriaud</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tenner</surname>
<given-names>A.J.</given-names>
</name>
</person-group>
<article-title>C1q: A fresh look upon an old molecule</article-title>
<source/>Mol. Immunol.
          <year>2017</year>
<volume>89</volume>
<fpage>73</fpage>
<lpage>83</lpage>
<pub-id pub-id-type="doi">10.1016/j.molimm.2017.05.025</pub-id>
<pub-id pub-id-type="pmid">28601358</pub-id>
</element-citation>
</ref>
<ref id="B2-cells-09-00062">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hogan</surname>
<given-names>K.A.</given-names>
</name>
<name>
<surname>Chini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chini</surname>
<given-names>E.N.</given-names>
</name>
</person-group>
<article-title>The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases</article-title>
<source/>Front. Immunol.
          <year>2019</year>
<volume>10</volume>
<fpage>1187</fpage>
<pub-id pub-id-type="doi">10.3389/fimmu.2019.01187</pub-id>
<pub-id pub-id-type="pmid">31214171</pub-id>
</element-citation>
</ref>
<ref id="B3-cells-09-00062">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers</article-title>
<source/>Annu. Rev. Pharmacol. Toxicol.
          <year>2001</year>
<volume>41</volume>
<fpage>317</fpage>
<lpage>345</lpage>
<pub-id pub-id-type="doi">10.1146/annurev.pharmtox.41.1.317</pub-id>
<pub-id pub-id-type="pmid">11264460</pub-id>
</element-citation>
</ref>
<ref id="B4-cells-09-00062">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malavasi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Deaglio</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Funaro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferrero</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Horenstein</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Ortolan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Vaisitti</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Aydin</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology</article-title>
<source/>Physiol. Rev.
          <year>2008</year>
<volume>88</volume>
<fpage>841</fpage>
<lpage>886</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00035.2007</pub-id>
<pub-id pub-id-type="pmid">18626062</pub-id>
</element-citation>
</ref>
<ref id="B5-cells-09-00062">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hirano</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>BST-1/CD157 regulates the humoral immune responses in vivo</article-title>
<source/>Chem. Immunol.
          <year>2000</year>
<volume>75</volume>
<fpage>235</fpage>
<lpage>255</lpage>
<pub-id pub-id-type="pmid">10851788</pub-id>
</element-citation>
</ref>
<ref id="B6-cells-09-00062">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishihara</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>History and Perspectives of Research in Bone Marrow Stromal Cell Antigen-1 (BST-1)/CD157: A Relative of ADP-Ribosyl Cyclase CD38</article-title>
<source/>Messenger
          <year>2014</year>
<volume>3</volume>
<fpage>15</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1166/msr.2014.1038</pub-id>
</element-citation>
</ref>
<ref id="B7-cells-09-00062">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quarona</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zaccarello</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chillemi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Brunetti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>V.K.</given-names>
</name>
<name>
<surname>Ferrero</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Funaro</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Horenstein</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Malavasi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>CD38 and CD157: A long journey from activation markers to multifunctional molecules</article-title>
<source/>Cytom. B. Clin. Cytom.
          <year>2013</year>
<volume>84</volume>
<fpage>207</fpage>
<lpage>217</lpage>
<pub-id pub-id-type="doi">10.1002/cyto.b.21092</pub-id>
</element-citation>
</ref>
<ref id="B8-cells-09-00062">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopatina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Inzhutova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Salmina</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>The roles of oxytocin and CD38 in social or parental behaviors</article-title>
<source/>Front. Neurosci.
          <year>2013</year>
<volume>6</volume>
<fpage>182</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2012.00182</pub-id>
<pub-id pub-id-type="pmid">23335873</pub-id>
</element-citation>
</ref>
<ref id="B9-cells-09-00062">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.X.</given-names>
</name>
<name>
<surname>Hirai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Torashima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lopatina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Shnayder</surname>
<given-names>N.A.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Seike</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CD38 is critical for social behaviour by regulating oxytocin secretion. CD38 is critical for social behaviour by regulating oxytocin secretion</article-title>
<source/>Nature
          <year>2007</year>
<volume>446</volume>
<fpage>41</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1038/nature05526</pub-id>
<pub-id pub-id-type="pmid">17287729</pub-id>
</element-citation>
</ref>
<ref id="B10-cells-09-00062">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Minabe</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Social memory, amnesia, and autism: Brain oxytocin secretion is regulated by NAD<sup>+</sup> metabolites and single nucleotide polymorphisms of CD38</article-title>
<source/>Neurochem. Int.
          <year>2012</year>
<volume>61</volume>
<fpage>828</fpage>
<lpage>838</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2012.01.030</pub-id>
<pub-id pub-id-type="pmid">22366648</pub-id>
</element-citation>
</ref>
<ref id="B11-cells-09-00062">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Somato-axodendritic release of oxytocin into the brain due to calcium amplification is essential for social memory</article-title>
<source/>J. Physiol. Sci.
          <year>2016</year>
<volume>66</volume>
<fpage>275</fpage>
<lpage>282</lpage>
<pub-id pub-id-type="doi">10.1007/s12576-015-0425-0</pub-id>
<pub-id pub-id-type="pmid">26586001</pub-id>
</element-citation>
</ref>
<ref id="B12-cells-09-00062">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>CD38 and its role in oxytocin secretion and social behavior</article-title>
<source/>Horm. Behav.
          <year>2012</year>
<volume>61</volume>
<fpage>351</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1016/j.yhbeh.2011.12.011</pub-id>
<pub-id pub-id-type="pmid">22227279</pub-id>
</element-citation>
</ref>
<ref id="B13-cells-09-00062">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satake</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Nakabayashi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Mizuta</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Hirota</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kubo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kawaguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsunoda</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson’s disease</article-title>
<source/>Nat. Genet.
          <year>2009</year>
<volume>41</volume>
<fpage>1303</fpage>
<lpage>1307</lpage>
<pub-id pub-id-type="doi">10.1038/ng.485</pub-id>
<pub-id pub-id-type="pmid">19915576</pub-id>
</element-citation>
</ref>
<ref id="B14-cells-09-00062">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ioannidis</surname>
<given-names>J.P.</given-names>
</name>
<name>
<surname>Aasly</surname>
<given-names>J.O.</given-names>
</name>
<name>
<surname>Annesi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Brice</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Van Broeckhoven</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Bertram</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Bozi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Crosiers</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Clarke</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Large-scale replication and heterogeneity in Parkinson disease genetic loci</article-title>
<source/>Neurology
          <year>2012</year>
<volume>79</volume>
<fpage>659</fpage>
<lpage>667</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e318264e353</pub-id>
<pub-id pub-id-type="pmid">22786590</pub-id>
</element-citation>
</ref>
<ref id="B15-cells-09-00062">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kasai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Lopatina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson’s Disease</article-title>
<source/>Front. Behav. Neurosci.
          <year>2017</year>
<volume>11</volume>
<fpage>75</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2017.00075</pub-id>
<pub-id pub-id-type="pmid">28515684</pub-id>
</element-citation>
</ref>
<ref id="B16-cells-09-00062">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopatina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fakhrul</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sumi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Furuhara</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson’s disease</article-title>
<source/>Front. Behav. Neurosci.
          <year>2014</year>
<volume>8</volume>
<fpage>133</fpage>
<pub-id pub-id-type="doi">10.3389/fnbeh.2014.00133</pub-id>
<pub-id pub-id-type="pmid">24795584</pub-id>
</element-citation>
</ref>
<ref id="B17-cells-09-00062">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yilmaz</surname>
<given-names>Ö.H.</given-names>
</name>
<name>
<surname>Katajisto</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lamming</surname>
<given-names>D.W.</given-names>
</name>
<name>
<surname>Gültekin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bauer-Rowe</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Sengupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Birso</surname>
<given-names>Y.K.</given-names>
</name>
<name>
<surname>Dursun</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yilmaz</surname>
<given-names>V.O.</given-names>
</name>
<name>
<surname>Selig</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>mTORC1 in the Paneth cell niche couples intestinal stem-cell function to calorie intake</article-title>
<source/>Nature
          <year>2012</year>
<volume>486</volume>
<fpage>490</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="doi">10.1038/nature11163</pub-id>
<pub-id pub-id-type="pmid">22722868</pub-id>
</element-citation>
</ref>
<ref id="B18-cells-09-00062">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fakhrul</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stanislav</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>T.S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>U.H.</given-names>
</name>
<name>
<surname>Kasai</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An immunohistochemical, enzymatic, and behavioral study of CD157/BST-1 as a neuroregulator</article-title>
<source/>BMC Neurosci.
          <year>2017</year>
<volume>1</volume>
<elocation-id>35</elocation-id>
<pub-id pub-id-type="doi">10.1186/s12868-017-0350-7</pub-id>
</element-citation>
</ref>
<ref id="B19-cells-09-00062">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riebold</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mankuta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lerer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Israel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nemanov</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Monakhov</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Levi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yirmiya</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yaari</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>All-trans retinoic acid upregulates reduced CD38 transcription in lymphoblastoid cell lines from Autism spectrum disorder</article-title>
<source/>Mol. Med.
          <year>2011</year>
<volume>17</volume>
<fpage>799</fpage>
<lpage>806</lpage>
<pub-id pub-id-type="doi">10.2119/molmed.2011.00080</pub-id>
<pub-id pub-id-type="pmid">21528155</pub-id>
</element-citation>
</ref>
<ref id="B20-cells-09-00062">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feldman</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Monakhov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pratt</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ebstein</surname>
<given-names>R.P.</given-names>
</name>
</person-group>
<article-title>Oxytocin Pathway Genes: Evolutionary Ancient System Impacting on Human Affiliation, Sociality, and Psychopathology</article-title>
<source/>Biol. Psychiatry
          <year>2016</year>
<volume>79</volume>
<fpage>174</fpage>
<lpage>184</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopsych.2015.08.008</pub-id>
<pub-id pub-id-type="pmid">26392129</pub-id>
</element-citation>
</ref>
<ref id="B21-cells-09-00062">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Anitha</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Asaka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.X.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Koizumi</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Two genetic variants of CD38 in subjects with autism spectrum disorder and controls</article-title>
<source/>Neurosci. Res.
          <year>2010</year>
<volume>67</volume>
<fpage>181</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1016/j.neures.2010.03.004</pub-id>
<pub-id pub-id-type="pmid">20435366</pub-id>
</element-citation>
</ref>
<ref id="B22-cells-09-00062">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krol</surname>
<given-names>K.M.</given-names>
</name>
<name>
<surname>Monakhov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>P.S.</given-names>
</name>
<name>
<surname>Ebstein</surname>
<given-names>R.P.</given-names>
</name>
<name>
<surname>Grossmann</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Genetic variation in CD38 and breastfeeding experience interact to impact infants’ attention to social eye cues</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2015</year>
<volume>112</volume>
<fpage>E5434</fpage>
<lpage>E5442</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1506352112</pub-id>
<pub-id pub-id-type="pmid">26371313</pub-id>
</element-citation>
</ref>
<ref id="B23-cells-09-00062">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hovey</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zettergren</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Jonsson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Melke</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Anckarsäter</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lichtenstein</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Westberg</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Associations between oxytocin-related genes and autistic-like traits</article-title>
<source/>Soc. Neurosci.
          <year>2014</year>
<volume>9</volume>
<fpage>378</fpage>
<lpage>386</lpage>
<pub-id pub-id-type="doi">10.1080/17470919.2014.897995</pub-id>
<pub-id pub-id-type="pmid">24635660</pub-id>
</element-citation>
</ref>
<ref id="B24-cells-09-00062">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vadgama</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Pittman</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nirmalananthan</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Yoshikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>De Rijk</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Rees</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kirov</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hughes</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo single-nucleotide and copy number variation in discordant monozygotic twins reveals disease-related genes</article-title>
<source/>Eur. J. Hum. Genet.
          <year>2019</year>
<volume>27</volume>
<fpage>1121</fpage>
<lpage>1133</lpage>
<pub-id pub-id-type="doi">10.1038/s41431-019-0376-7</pub-id>
<pub-id pub-id-type="pmid">30886340</pub-id>
</element-citation>
</ref>
<ref id="B25-cells-09-00062">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lerer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Levi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Israel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yaari</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nemanov</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mankuta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nurit</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ebstein</surname>
<given-names>R.P.</given-names>
</name>
</person-group>
<article-title>Low CD38 expression in lymphoblastoid cells and haplotypes are both associated with autism in a family-based study</article-title>
<source/>Autism Res.
          <year>2010</year>
<volume>3</volume>
<fpage>293</fpage>
<lpage>302</lpage>
<pub-id pub-id-type="doi">10.1002/aur.156</pub-id>
<pub-id pub-id-type="pmid">21182206</pub-id>
</element-citation>
</ref>
<ref id="B26-cells-09-00062">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McQuaid</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>McInnis</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Matheson</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Anisman</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Oxytocin and Social Sensitivity: Gene Polymorphisms in Relation to Depressive Symptoms and Suicidal Ideation</article-title>
<source/>Front. Hum. Neurosci.
          <year>2016</year>
<volume>10</volume>
<fpage>358</fpage>
<pub-id pub-id-type="doi">10.3389/fnhum.2016.00358</pub-id>
<pub-id pub-id-type="pmid">27486392</pub-id>
</element-citation>
</ref>
<ref id="B27-cells-09-00062">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.S.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S.P.</given-names>
</name>
</person-group>
<article-title>Genes Related to Oxytocin and Arginine-Vasopressin Pathways: Associations with Autism Spectrum Disorders</article-title>
<source/>Neurosci. Bull.
          <year>2017</year>
<volume>33</volume>
<fpage>238</fpage>
<lpage>246</lpage>
<pub-id pub-id-type="doi">10.1007/s12264-017-0120-7</pub-id>
<pub-id pub-id-type="pmid">28283809</pub-id>
</element-citation>
</ref>
<ref id="B28-cells-09-00062">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sauer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Montag</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wörner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kirsch</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Reuter</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Effects of a common variant in the CD38 gene on social processing in an oxytocin challenge study: Possible links to autism</article-title>
<source/>Neuropsychopharmacology
          <year>2012</year>
<volume>37</volume>
<fpage>1474</fpage>
<lpage>1482</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2011.333</pub-id>
<pub-id pub-id-type="pmid">22278094</pub-id>
</element-citation>
</ref>
<ref id="B29-cells-09-00062">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kucharska</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kot</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Biernacka</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zimowski</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rogoza</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rybakowski</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Kostecka</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bednarska-Makaruk</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Interaction between polymorphisms of the oxytocinergic system genes and emotion perception in inpatients with anorexia nervosa</article-title>
<source/>Eur. Eat. Disord. Rev.
          <year>2019</year>
<volume>27</volume>
<fpage>481</fpage>
<lpage>494</lpage>
<pub-id pub-id-type="doi">10.1002/erv.2698</pub-id>
<pub-id pub-id-type="pmid">31385420</pub-id>
</element-citation>
</ref>
<ref id="B30-cells-09-00062">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parris</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Grunebaum</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Galfalvy</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Andronikashvili</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Burke</surname>
<given-names>A.K.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.Y.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>J.J.</given-names>
</name>
</person-group>
<article-title>Attempted suicide and oxytocin-related gene polymorphisms</article-title>
<source/>J. Affect. Disord.
          <year>2018</year>
<volume>238</volume>
<fpage>62</fpage>
<lpage>68</lpage>
<pub-id pub-id-type="doi">10.1016/j.jad.2018.05.022</pub-id>
<pub-id pub-id-type="pmid">29860184</pub-id>
</element-citation>
</ref>
<ref id="B31-cells-09-00062">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>The association between CD157/BST1 polymorphisms and the susceptibility of Parkinson’s disease: A meta-analysis</article-title>
<source/>Neuropsychiatr. Dis. Treat.
          <year>2019</year>
<volume>15</volume>
<fpage>1089</fpage>
<lpage>1102</lpage>
<pub-id pub-id-type="doi">10.2147/NDT.S190935</pub-id>
<pub-id pub-id-type="pmid">31118642</pub-id>
</element-citation>
</ref>
<ref id="B32-cells-09-00062">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M.J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>R.M.</given-names>
</name>
</person-group>
<article-title>BST1 rs11724635 interacts with environmental factors to increase the risk of Parkinson’s disease in a Taiwanese population</article-title>
<source/>Parkinsonism Relat. Disord.
          <year>2014</year>
<volume>20</volume>
<fpage>280</fpage>
<lpage>283</lpage>
<pub-id pub-id-type="doi">10.1016/j.parkreldis.2013.11.009</pub-id>
<pub-id pub-id-type="pmid">24342025</pub-id>
</element-citation>
</ref>
<ref id="B33-cells-09-00062">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Al Mahmuda</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yagi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamagishi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Association Study between the CD157/BST1 Gene and Autism Spectrum Disorders in a Japanese Population</article-title>
<source/>Brain Sci.
          <year>2015</year>
<volume>5</volume>
<fpage>188</fpage>
<lpage>200</lpage>
<pub-id pub-id-type="doi">10.3390/brainsci5020188</pub-id>
<pub-id pub-id-type="pmid">26010484</pub-id>
</element-citation>
</ref>
<ref id="B34-cells-09-00062">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kamimura</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Inoue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hori</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Lopatina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Cyclic ADP-ribose as an endogenous inhibitor of the mTOR pathway downstream of dopamine receptors in the mouse striatum</article-title>
<source/>J. Neural. Transm. (Vienna)
          <year>2018</year>
<volume>125</volume>
<fpage>17</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="doi">10.1007/s00702-016-1666-7</pub-id>
<pub-id pub-id-type="pmid">28025713</pub-id>
</element-citation>
</ref>
<ref id="B35-cells-09-00062">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizuguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Otsuka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishina</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Katada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Neuronal localization of CD38 antigen in the human brain</article-title>
<source/>Brain Res.
          <year>1995</year>
<volume>697</volume>
<fpage>2340</fpage>
<lpage>2352</lpage>
<pub-id pub-id-type="doi">10.1016/0006-8993(95)00885-T</pub-id>
</element-citation>
</ref>
<ref id="B36-cells-09-00062">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Amina</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yuhi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.X.</given-names>
</name>
<name>
<surname>Hashii</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cyclic ADP-Ribose and heat regulate oxytocin release via CD38 and TRPM2 in the hypothalamus during social or psychological stress in mice</article-title>
<source/>Front. Neurosci.
          <year>2016</year>
<volume>10</volume>
<fpage>304</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2016.00304</pub-id>
<pub-id pub-id-type="pmid">27499729</pub-id>
</element-citation>
</ref>
<ref id="B37-cells-09-00062">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akimoto</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kamiyama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yamafuji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Seike</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kido</surname>
<given-names>M.A.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Noda</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Immunohistochemistry of CD38 in Different Cell Types in the Hypothalamus and Pituitary of Male Mice</article-title>
<source/>Messenger
          <year>2013</year>
<volume>2</volume>
<fpage>54</fpage>
<lpage>61</lpage>
<pub-id pub-id-type="doi">10.1166/msr.2013.1021</pub-id>
</element-citation>
</ref>
<ref id="B38-cells-09-00062">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hattori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kaji</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Jureepon</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Takarada-Iemata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Minh Ta</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Manh Le</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Konno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hirai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Shiraishi</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CD38 positively regulates postnatal development of astrocytes cell-autonomously and oligodendrocytes non-cell-autonomously</article-title>
<source/>Glia
          <year>2017</year>
<volume>65</volume>
<fpage>974</fpage>
<lpage>989</lpage>
<pub-id pub-id-type="doi">10.1002/glia.23139</pub-id>
<pub-id pub-id-type="pmid">28295574</pub-id>
</element-citation>
</ref>
<ref id="B39-cells-09-00062">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roboon</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hattori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishii</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Takarada-Iemata</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>T.M.</given-names>
</name>
<name>
<surname>Shiraishi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ozaki</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletion of CD38 Suppresses Glial Activation and Neuroinflammation in a Mouse Model of Demyelination</article-title>
<source/>Front. Cell. Neurosci.
          <year>2019</year>
<volume>13</volume>
<fpage>258</fpage>
<pub-id pub-id-type="doi">10.3389/fncel.2019.00258</pub-id>
<pub-id pub-id-type="pmid">31244614</pub-id>
</element-citation>
</ref>
<ref id="B40-cells-09-00062">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mizuguchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Otsuka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ikeda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Ultrastructural localization of CD38 immunoreactivity in rat brain</article-title>
<source/>Brain Res.
          <year>1997</year>
<volume>756</volume>
<fpage>52</fpage>
<lpage>60</lpage>
<pub-id pub-id-type="doi">10.1016/S0006-8993(97)00117-0</pub-id>
<pub-id pub-id-type="pmid">9187313</pub-id>
</element-citation>
</ref>
<ref id="B41-cells-09-00062">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Vitamin A Deficiency Induces Autistic-Like Behaviors in Rats by Regulating the RARβ-CD38-Oxytocin Axis in the Hypothalamus</article-title>
<source/>Mol. Nutr. Food Res.
          <year>2018</year>
<volume>62</volume>
<fpage>5</fpage>
<pub-id pub-id-type="doi">10.1002/mnfr.201700754</pub-id>
<pub-id pub-id-type="pmid">29266770</pub-id>
</element-citation>
</ref>
<ref id="B42-cells-09-00062">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martucci</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Amar</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chaussenot</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Benet</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>De Zélicourt</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nosjean</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Launay</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Callebert</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sebrié</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A multiscale analysis in CD38<sup>-/-</sup> mice unveils major prefrontal cortex dysfunctions</article-title>
<source/>FASEB J.
          <year>2019</year>
<volume>33</volume>
<fpage>5823</fpage>
<lpage>5835</lpage>
<pub-id pub-id-type="doi">10.1096/fj.201800489R</pub-id>
<pub-id pub-id-type="pmid">30844310</pub-id>
</element-citation>
</ref>
<ref id="B43-cells-09-00062">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nelissen</surname>
<given-names>T.P.</given-names>
</name>
<name>
<surname>Bamford</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Tochitani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Akkus</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kudzinskas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yokoi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Burbach</surname>
<given-names>J.P.H.</given-names>
</name>
<name>
<surname>Matsuzaki</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CD38 is Required for Dendritic Organization in Visual Cortex and Hippocampus</article-title>
<source/>Neuroscience
          <year>2018</year>
<volume>372</volume>
<fpage>114</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.12.050</pub-id>
<pub-id pub-id-type="pmid">29306053</pub-id>
</element-citation>
</ref>
<ref id="B44-cells-09-00062">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruzzone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Verderio</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Schenk</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Fedele</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Zocchi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Matteoli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>De Flora</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Glutamate-mediated overexpression of CD38 in astrocytes cultured with neurones</article-title>
<source/>J. Neurochem.
          <year>2004</year>
<volume>8</volume>
<fpage>264</fpage>
<lpage>272</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2003.02326.x</pub-id>
</element-citation>
</ref>
<ref id="B45-cells-09-00062">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayakawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Esposito</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Terasaki</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Lo</surname>
<given-names>E.H.</given-names>
</name>
</person-group>
<article-title>Transfer of mitochondria from astrocytes to neurons after stroke</article-title>
<source/>Nature
          <year>2016</year>
<volume>535</volume>
<fpage>551</fpage>
<lpage>555</lpage>
<pub-id pub-id-type="doi">10.1038/nature18928</pub-id>
<pub-id pub-id-type="pmid">27466127</pub-id>
</element-citation>
</ref>
<ref id="B46-cells-09-00062">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kou</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Banerjee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Eudy</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Persidsky</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Borgmann</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sakhuja</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Deshpande</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Walseth</surname>
<given-names>T.F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CD38 regulation in activated astrocytes: Implications for neuroinflammation and HIV-1 brain infection</article-title>
<source/>J. Neurosci. Res.
          <year>2009</year>
<volume>87</volume>
<fpage>2326</fpage>
<lpage>2339</lpage>
<pub-id pub-id-type="doi">10.1002/jnr.22060</pub-id>
<pub-id pub-id-type="pmid">19365854</pub-id>
</element-citation>
</ref>
<ref id="B47-cells-09-00062">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meditz</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Haas</surname>
<given-names>M.K.</given-names>
</name>
<name>
<surname>Folkvord</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Melander</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>McCarter</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mawhinney</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>T.B.</given-names>
</name>
<name>
<surname>Lie</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Coakley</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>HLA-DR<sup>+</sup> CD38<sup>+</sup> CD4<sup>+</sup> T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo</article-title>
<source/>J. Virol.
          <year>2011</year>
<volume>85</volume>
<fpage>10189</fpage>
<lpage>10200</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.02529-10</pub-id>
<pub-id pub-id-type="pmid">21813616</pub-id>
</element-citation>
</ref>
<ref id="B48-cells-09-00062">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lévy</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Thiébaut</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Gougeon</surname>
<given-names>M.L.</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Weiss</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Girard</surname>
<given-names>P.M.</given-names>
</name>
<name>
<surname>Venet</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Morlat</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Poirier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lascaux</surname>
<given-names>A.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV</article-title>
<source/>AIDS
          <year>2012</year>
<volume>26</volume>
<fpage>711</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="doi">10.1097/QAD.0b013e3283519214</pub-id>
<pub-id pub-id-type="pmid">22301410</pub-id>
</element-citation>
</ref>
<ref id="B49-cells-09-00062">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>T.J.</given-names>
</name>
<name>
<surname>Tzeng</surname>
<given-names>Y.K.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>W.W.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>C.A.</given-names>
</name>
<name>
<surname>Kuo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chien</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Tracking the engraftment and regenerative capabilities of transplanted lung stem cells using fluorescent nanodiamonds</article-title>
<source/>Nat. Nanotechnol.
          <year>2013</year>
<volume>8</volume>
<fpage>682</fpage>
<lpage>689</lpage>
<pub-id pub-id-type="doi">10.1038/nnano.2013.147</pub-id>
<pub-id pub-id-type="pmid">23912062</pub-id>
</element-citation>
</ref>
<ref id="B50-cells-09-00062">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pentinmikko</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Iqbal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cognetta</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Suciu</surname>
<given-names>R.M.</given-names>
</name>
<name>
<surname>Roper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Luopajärvi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Markelin</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gopalakrishnan</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Notum produced by Paneth cells attenuates regeneration of aged intestinal epithelium</article-title>
<source/>Nature
          <year>2019</year>
<volume>571</volume>
<fpage>398</fpage>
<lpage>402</lpage>
<pub-id pub-id-type="doi">10.1038/s41586-019-1383-0</pub-id>
<pub-id pub-id-type="pmid">31292548</pub-id>
</element-citation>
</ref>
<ref id="B51-cells-09-00062">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wakabayashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Suehiro</surname>
<given-names>J.I.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kawaji</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Iba</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kouno</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishikawa-Kato</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Furuno</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Takara</surname>
<given-names>K.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties</article-title>
<source/>Cell Stem Cell
          <year>2018</year>
<volume>22</volume>
<fpage>384</fpage>
<lpage>397</lpage>
<pub-id pub-id-type="doi">10.1016/j.stem.2018.01.010</pub-id>
<pub-id pub-id-type="pmid">29429943</pub-id>
</element-citation>
</ref>
<ref id="B52-cells-09-00062">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kfir</surname>
<given-names>S.H.</given-names>
</name>
<name>
<surname>Barash</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Calorie restriction and rapamycin administration induce stem cell self-renewal and consequent development and production in the mammary gland</article-title>
<source/>Exp. Cell Res.
          <year>2019</year>
<volume>382</volume>
<fpage>111477</fpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2019.06.022</pub-id>
<pub-id pub-id-type="pmid">31242443</pub-id>
</element-citation>
</ref>
<ref id="B53-cells-09-00062">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ortolan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Augeri</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fissolo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Musso</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Funaro</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>CD157: From immunoregulatory protein to potential therapeutic target</article-title>
<source/>Immunol. Lett.
          <year>2019</year>
<volume>205</volume>
<fpage>59</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.imlet.2018.06.007</pub-id>
<pub-id pub-id-type="pmid">29936181</pub-id>
</element-citation>
</ref>
<ref id="B54-cells-09-00062">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lo Buono</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Parrotta</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Morone</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bovino</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nacci</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ortolan</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Horenstein</surname>
<given-names>A.L.</given-names>
</name>
<name>
<surname>Inzhutova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ferrero</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Funaro</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes</article-title>
<source/>J. Biol. Chem.
          <year>2011</year>
<volume>286</volume>
<fpage>18681</fpage>
<lpage>18691</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.227876</pub-id>
<pub-id pub-id-type="pmid">21478153</pub-id>
</element-citation>
</ref>
<ref id="B55-cells-09-00062">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takakura</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Discovery of a Vascular Endothelial Stem Cell (VESC) Population Required for Vascular Regeneration and Tissue Maintenance</article-title>
<source/>Circ. J.
          <year>2018</year>
<volume>83</volume>
<fpage>12</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1253/circj.CJ-18-1180</pub-id>
<pub-id pub-id-type="pmid">30487375</pub-id>
</element-citation>
</ref>
<ref id="B56-cells-09-00062">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hashii</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Higuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Gabata</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tsubomoto</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iwatsuka</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Teramachi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kamijima</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Matsukawa</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Ca2+-Calmodulin-Dependent Protein Kinase II Inhibitor Suppresses Cell Migration of CD38-Expressing Human Embryonic Kidney Cells: A Preliminary Report</article-title>
<source/>Messenger
          <year>2018</year>
<volume>6</volume>
<fpage>85</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1166/msr.2018.1064</pub-id>
</element-citation>
</ref>
<ref id="B57-cells-09-00062">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colbran</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A.M.</given-names>
</name>
</person-group>
<article-title>Calcium/calmodulin-dependent protein kinase II and synaptic plasticity</article-title>
<source/>Curr. Opin. Neurobiol.
          <year>2004</year>
<volume>14</volume>
<fpage>318</fpage>
<lpage>327</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2004.05.008</pub-id>
<pub-id pub-id-type="pmid">15194112</pub-id>
</element-citation>
</ref>
<ref id="B58-cells-09-00062">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takasawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ishida</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nata</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Noguchi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tohgo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yonekura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fujisawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Requirement of calmodulin-dependent protein kinase II in cyclic ADP-ribose-mediated intracellular Ca<sup>2+</sup> mobilization</article-title>
<source/>J. Biol. Chem.
          <year>1995</year>
<volume>270</volume>
<fpage>30257</fpage>
<lpage>30259</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.270.51.30257</pub-id>
<pub-id pub-id-type="pmid">8530441</pub-id>
</element-citation>
</ref>
<ref id="B59-cells-09-00062">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohta</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hartwig</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Actin filament cross-linking by chicken gizzard filamin is regulated by phosphorylation in vitro</article-title>
<source/>Biochemistry
          <year>1995</year>
<volume>34</volume>
<fpage>6745</fpage>
<lpage>6754</lpage>
<pub-id pub-id-type="doi">10.1021/bi00020a020</pub-id>
<pub-id pub-id-type="pmid">7756305</pub-id>
</element-citation>
</ref>
<ref id="B60-cells-09-00062">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoffman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Alexov</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sanabria</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Waxham</surname>
<given-names>M.N.</given-names>
</name>
</person-group>
<article-title>Cytoskeletal-like Filaments of Ca<sup>2+</sup>-Calmodulin-Dependent Protein Kinase II Are Formed in a Regulated and Zn<sup>2+</sup>-Dependent Manner</article-title>
<source/>Biochemistry
          <year>2017</year>
<volume>56</volume>
<fpage>2149</fpage>
<lpage>2160</lpage>
<pub-id pub-id-type="doi">10.1021/acs.biochem.7b00028</pub-id>
<pub-id pub-id-type="pmid">28318265</pub-id>
</element-citation>
</ref>
<ref id="B61-cells-09-00062">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Yap promotes hepatocellular carcinoma metastasis and mobilization via governing cofilin/F-actin/lamellipodium axis by regulation of JNK/Bnip3/SERCA/CaMKII pathways</article-title>
<source/>Redox Biol.
          <year>2018</year>
<volume>14</volume>
<fpage>59</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1016/j.redox.2017.08.013</pub-id>
<pub-id pub-id-type="pmid">28869833</pub-id>
</element-citation>
</ref>
<ref id="B62-cells-09-00062">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zumaquero</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Muñoz</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Cobo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lucena</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Pavón</surname>
<given-names>E.J.</given-names>
</name>
<name>
<surname>Martín</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Navarro</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>García-Pérez</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ariza-Veguillas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Malavasi</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exosomes from human lymphoblastoid B cells express enzymatically active CD38 that is associated with signaling complexes containing CD81, Hsc-70 and Lyn</article-title>
<source/>Exp. Cell Res.
          <year>2010</year>
<volume>316</volume>
<fpage>2692</fpage>
<lpage>2706</lpage>
<pub-id pub-id-type="doi">10.1016/j.yexcr.2010.05.032</pub-id>
<pub-id pub-id-type="pmid">20570673</pub-id>
</element-citation>
</ref>
<ref id="B63-cells-09-00062">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>W.J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.H.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Determinants of the membrane orientation of a calcium signaling enzyme CD38</article-title>
<source/>Biochim. Biophys. Acta.
          <year>2015</year>
<volume>1853</volume>
<fpage>2095</fpage>
<lpage>2103</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbamcr.2014.10.028</pub-id>
<pub-id pub-id-type="pmid">25447548</pub-id>
</element-citation>
</ref>
<ref id="B64-cells-09-00062">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Z.Y.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.C.</given-names>
</name>
</person-group>
<article-title>Cytosolic interaction of type III human CD38 with CIB1 modulates cellular cyclic ADP-ribose levels</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2017</year>
<pub-id pub-id-type="doi">10.1073/pnas.1703718114</pub-id>
<pub-id pub-id-type="pmid">28720704</pub-id>
</element-citation>
</ref>
<ref id="B65-cells-09-00062">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>Q.W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.M.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.J.</given-names>
</name>
</person-group>
<article-title>The transferrin receptor CD71 regulates type II CD38, revealing tight topological compartmentalization of intracellular cyclic ADP-ribose production</article-title>
<source/>J. Biol. Chem.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1074/jbc.RA119.010010</pub-id>
<pub-id pub-id-type="pmid">31434741</pub-id>
</element-citation>
</ref>
<ref id="B66-cells-09-00062">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>G.J.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Q.W.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>Y.N.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.J.</given-names>
</name>
</person-group>
<article-title>CD38 produces nicotinic acid adenosine dinucleotide phosphate in the lysosome</article-title>
<source/>J. Biol. Chem.
          <year>2018</year>
<volume>293</volume>
<fpage>8151</fpage>
<lpage>8160</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.RA118.002113</pub-id>
<pub-id pub-id-type="pmid">29632067</pub-id>
</element-citation>
</ref>
<ref id="B67-cells-09-00062">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>W.K.</given-names>
</name>
<name>
<surname>Bolton</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Cortopassi</surname>
<given-names>W.A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Maciejewska</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jacobson</surname>
<given-names>M.P.</given-names>
</name>
<name>
<surname>Garnham</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ruas</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Parrington</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Synthesis of the Ca<sup>2+</sup>-mobilizing messengers NAADP and cADPR by intracellular CD38 enzyme in the mouse heart: Role in β-adrenoceptor signaling</article-title>
<source/>J. Biol. Chem.
          <year>2017</year>
<volume>292</volume>
<fpage>13243</fpage>
<lpage>13257</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M117.789347</pub-id>
<pub-id pub-id-type="pmid">28539361</pub-id>
</element-citation>
</ref>
<ref id="B68-cells-09-00062">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kashio</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tominaga</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>The TRPM2 channel: A thermo-sensitive metabolic sensor</article-title>
<source/>Channels (Austin)
          <year>2017</year>
<volume>11</volume>
<fpage>426</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="doi">10.1080/19336950.2017.1344801</pub-id>
<pub-id pub-id-type="pmid">28633002</pub-id>
</element-citation>
</ref>
<ref id="B69-cells-09-00062">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uchida</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Dezaki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoneshiro</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tominaga</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Iwasaki</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Involvement of thermosensitive TRP channels in energy metabolism</article-title>
<source/>J. Physiol. Sci.
          <year>2017</year>
<volume>67</volume>
<fpage>549</fpage>
<lpage>560</lpage>
<pub-id pub-id-type="pmid">28656459</pub-id>
</element-citation>
</ref>
<ref id="B70-cells-09-00062">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fliegert</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bauche</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wolf Pérez</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Watt</surname>
<given-names>J.M.</given-names>
</name>
<name>
<surname>Rozewitz</surname>
<given-names>M.D.</given-names>
</name>
<name>
<surname>Winzer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Janus</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rosche</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Harneit</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>2’-Deoxyadenosine 5’-diphosphoribose is an endogenous TRPM2 superagonist</article-title>
<source/>Nat. Chem. Biol.
          <year>2017</year>
<volume>13</volume>
<fpage>1036</fpage>
<lpage>1044</lpage>
<pub-id pub-id-type="doi">10.1038/nchembio.2415</pub-id>
<pub-id pub-id-type="pmid">28671679</pub-id>
</element-citation>
</ref>
<ref id="B71-cells-09-00062">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yuhi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Amina</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.X.</given-names>
</name>
<name>
<surname>Lopatina</surname>
<given-names>O.</given-names>
</name>
</person-group>
<article-title>Oxytocin release via activation of TRPM2 and CD38 in the hypothalamus during hyperthermia in mice: Implication for autism spectrum disorder</article-title>
<source/>Neurochem. Int.
          <year>2018</year>
<volume>119</volume>
<fpage>42</fpage>
<lpage>48</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuint.2017.07.009</pub-id>
<pub-id pub-id-type="pmid">28736241</pub-id>
</element-citation>
</ref>
<ref id="B72-cells-09-00062">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rah</surname>
<given-names>S.Y.</given-names>
</name>
<name>
<surname>Kwak</surname>
<given-names>J.Y.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>Y.J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>U.H.</given-names>
</name>
</person-group>
<article-title>ADP-ribose/TRPM2-mediated Ca<sup>2+</sup> signaling is essential for cytolytic degranulation and antitumor activity of natural killer cells</article-title>
<source/>Sci. Rep.
          <year>2015</year>
<volume>5</volume>
<fpage>9482</fpage>
<pub-id pub-id-type="doi">10.1038/srep09482</pub-id>
<pub-id pub-id-type="pmid">25879940</pub-id>
</element-citation>
</ref>
<ref id="B73-cells-09-00062">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.Y.</given-names>
</name>
<name>
<surname>Lau</surname>
<given-names>C.P.</given-names>
</name>
<name>
<surname>Tse</surname>
<given-names>H.F.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.R.</given-names>
</name>
</person-group>
<article-title>Cyclic ADP ribose is a novel regulator of intracellular Ca<sup>2+</sup> oscillations in human bone marrow mesenchymal stem cells</article-title>
<source/>J. Cell. Mol. Med.
          <year>2011</year>
<volume>15</volume>
<fpage>2684</fpage>
<lpage>2696</lpage>
<pub-id pub-id-type="doi">10.1111/j.1582-4934.2011.01263.x</pub-id>
<pub-id pub-id-type="pmid">21251217</pub-id>
</element-citation>
</ref>
<ref id="B74-cells-09-00062">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lange</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Partida-Sanchez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fleig</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Penner</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>TRPM2 functions as a lysosomal Ca<sup>2+</sup>-release channel in beta cells</article-title>
<source/>Sci. Signal.
          <year>2009</year>
<pub-id pub-id-type="doi">10.1126/scisignal.2000278</pub-id>
<pub-id pub-id-type="pmid">19454650</pub-id>
</element-citation>
</ref>
<ref id="B75-cells-09-00062">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heiner</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Radukina</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Eisfeld</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kühn</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Lückhoff</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Regulation of TRPM2 channels in neutrophil granulocytes by ADP-ribose: A promising pharmacological target</article-title>
<source/>Naunyn Schmiedebergs Arch. Pharmacol.
          <year>2005</year>
<volume>371</volume>
<fpage>325</fpage>
<lpage>333</lpage>
<pub-id pub-id-type="doi">10.1007/s00210-005-1033-y</pub-id>
<pub-id pub-id-type="pmid">15841395</pub-id>
</element-citation>
</ref>
<ref id="B76-cells-09-00062">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>García-Rodríguez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rosal-Vela</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Botta</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Cumba Garcia</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Zumaquero</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Prados-Maniviesa</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cerezo-Walli</surname>
<given-names>S.D.</given-names>
</name>
<name>
<surname>Lo Buono</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Robles-Guirado</surname>
<given-names>J.Á.</given-names>
</name>
<name>
<surname>Guerrero</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism</article-title>
<source/>Sci. Rep.
          <year>2018</year>
<volume>8</volume>
<fpage>3357</fpage>
<pub-id pub-id-type="pmid">29463868</pub-id>
</element-citation>
</ref>
<ref id="B77-cells-09-00062">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopatina</surname>
<given-names>O.L.</given-names>
</name>
<name>
<surname>Furuhara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Salmina</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Communication Impairment in Ultrasonic Vocal Repertoire during the Suckling Period of Cd157 Knockout Mice: Transient Improvement by Oxytocin</article-title>
<source/>Front. Neurosci.
          <year>2017</year>
<volume>11</volume>
<fpage>266</fpage>
<pub-id pub-id-type="doi">10.3389/fnins.2017.00266</pub-id>
<pub-id pub-id-type="pmid">28566999</pub-id>
</element-citation>
</ref>
<ref id="B78-cells-09-00062">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mizuno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cherepanov</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Fakhrul</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Deguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoshihara</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shuto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Lipo-oxytocin-1, a Novel Oxytocin Analog Conjugated with Two Palmitoyl Groups, Has Long-Lasting Effects on Anxiety-Related Behavior and Social Avoidance in CD157 Knockout Mice</article-title>
<source/>Brain Sci.
          <year>2015</year>
<volume>5</volume>
<fpage>3</fpage>
<lpage>13</lpage>
<pub-id pub-id-type="doi">10.3390/brainsci5010003</pub-id>
<pub-id pub-id-type="pmid">25612002</pub-id>
</element-citation>
</ref>
<ref id="B79-cells-09-00062">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ichinose</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Cherepanov</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Shabalova</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yuhi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Horike</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Development of a Highly Potent Analogue and a Long-Acting Analogue of Oxytocin for the Treatment of Social Impairment-Like Behaviors</article-title>
<source/>J. Med. Chem.
          <year>2019</year>
<volume>62</volume>
<fpage>3297</fpage>
<lpage>3310</lpage>
<pub-id pub-id-type="doi">10.1021/acs.jmedchem.8b01691</pub-id>
<pub-id pub-id-type="pmid">30896946</pub-id>
</element-citation>
</ref>
<ref id="B80-cells-09-00062">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Deguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Harashima</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Furuhara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yuhi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice</article-title>
<source/>Commun. Biol.
          <year>2019</year>
<volume>2</volume>
<fpage>76</fpage>
<pub-id pub-id-type="doi">10.1038/s42003-019-0325-6</pub-id>
<pub-id pub-id-type="pmid">30820471</pub-id>
</element-citation>
</ref>
<ref id="B81-cells-09-00062">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cherepanov</surname>
<given-names>S.M.</given-names>
</name>
<name>
<surname>Akther</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shabalova</surname>
<given-names>A.A.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ichinose</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shuto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of Three Lipidated Oxytocin Analogs on Behavioral Deficits in CD38 Knockout Mice</article-title>
<source/>Brain Sci.
          <year>2017</year>
<volume>7</volume>
<elocation-id>132</elocation-id>
<pub-id pub-id-type="doi">10.3390/brainsci7100132</pub-id>
<pub-id pub-id-type="pmid">29035307</pub-id>
</element-citation>
</ref>
<ref id="B82-cells-09-00062">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adriaan Bouwknecht</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Olivier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Paylor</surname>
<given-names>R.E.</given-names>
</name>
</person-group>
<article-title>The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: A review of pharmacological and genetic studies in the mouse</article-title>
<source/>Neurosci. Biobehav. Rev.
          <year>2007</year>
<volume>31</volume>
<fpage>41</fpage>
<lpage>59</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2006.02.002</pub-id>
<pub-id pub-id-type="pmid">16618509</pub-id>
</element-citation>
</ref>
<ref id="B83-cells-09-00062">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Harker</surname>
<given-names>C.T.</given-names>
</name>
<name>
<surname>Vander</surname>
<given-names>A.J.</given-names>
</name>
<name>
<surname>Kluger</surname>
<given-names>M.J.</given-names>
</name>
</person-group>
<article-title>Hyperthermia induced by open-field stress is blocked by salicylate</article-title>
<source/>Physiol. Behav.
          <year>1986</year>
<volume>36</volume>
<fpage>1179</fpage>
<lpage>1182</lpage>
<pub-id pub-id-type="doi">10.1016/0031-9384(86)90497-X</pub-id>
<pub-id pub-id-type="pmid">3725924</pub-id>
</element-citation>
</ref>
<ref id="B84-cells-09-00062">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinkers</surname>
<given-names>C.H.</given-names>
</name>
<name>
<surname>Penning</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hellhammer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Verster</surname>
<given-names>J.C.</given-names>
</name>
<name>
<surname>Klaessens</surname>
<given-names>J.H.</given-names>
</name>
<name>
<surname>Olivier</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kalkman</surname>
<given-names>C.J.</given-names>
</name>
</person-group>
<article-title>The effect of stress on core and peripheral body temperature in humans</article-title>
<source/>Stress
          <year>2013</year>
<volume>16</volume>
<fpage>520</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="doi">10.3109/10253890.2013.807243</pub-id>
<pub-id pub-id-type="pmid">23790072</pub-id>
</element-citation>
</ref>
<ref id="B85-cells-09-00062">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groenink</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Vinkers</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>van Oorschot</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Olivier</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Models of anxiety: Stress-induced hyperthermia (SIH) in singly housed mice</article-title>
<source/>Curr. Protoc. Pharmacol.
          <year>2009</year>
<volume>45</volume>
<fpage>5</fpage>
<lpage>16</lpage>
<pub-id pub-id-type="doi">10.1002/0471141755.ph0516s45</pub-id>
<pub-id pub-id-type="pmid">22294397</pub-id>
</element-citation>
</ref>
<ref id="B86-cells-09-00062">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehler</surname>
<given-names>M.F.</given-names>
</name>
<name>
<surname>Purpura</surname>
<given-names>D.P.</given-names>
</name>
</person-group>
<article-title>Autism, fever, epigenetics and the locus coeruleus</article-title>
<source/>Brain Res. Rev.
          <year>2009</year>
<volume>59</volume>
<fpage>388</fpage>
<lpage>392</lpage>
<pub-id pub-id-type="doi">10.1016/j.brainresrev.2008.11.001</pub-id>
<pub-id pub-id-type="pmid">19059284</pub-id>
</element-citation>
</ref>
<ref id="B87-cells-09-00062">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curran</surname>
<given-names>L.K.</given-names>
</name>
<name>
<surname>Newschaffer</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>L.C.</given-names>
</name>
<name>
<surname>Crawford</surname>
<given-names>S.O.</given-names>
</name>
<name>
<surname>Johnston</surname>
<given-names>M.V.</given-names>
</name>
<name>
<surname>Zimmerman</surname>
<given-names>A.W.</given-names>
</name>
</person-group>
<article-title>Behaviors associated with fever in children with autism spectrum disorders</article-title>
<source/>Pediatrics
          <year>2007</year>
<volume>120</volume>
<fpage>e1386</fpage>
<lpage>e1392</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2007-0360</pub-id>
<pub-id pub-id-type="pmid">18055656</pub-id>
</element-citation>
</ref>
<ref id="B88-cells-09-00062">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naviaux</surname>
<given-names>R.K.</given-names>
</name>
</person-group>
<article-title>Antipurinergic therapy for autism-An in-depth review</article-title>
<source/>Mitochondrion
          <year>2018</year>
<volume>43</volume>
<fpage>1</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1016/j.mito.2017.12.007</pub-id>
<pub-id pub-id-type="pmid">29253638</pub-id>
</element-citation>
</ref>
<ref id="B89-cells-09-00062">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owada</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fujioka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Uno</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kuwabara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Quantitative facial expression analysis revealed the efficacy and time course of oxytocin in autism</article-title>
<source/>Brain
          <year>2019</year>
<volume>142</volume>
<fpage>2127</fpage>
<lpage>2136</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awz126</pub-id>
<pub-id pub-id-type="pmid">31096266</pub-id>
</element-citation>
</ref>
<ref id="B90-cells-09-00062">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamasue</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Okada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Fujioka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Uno</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kuwabara</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mori</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effect of intranasal oxytocin on the core social symptoms of autism spectrum disorder: A randomized clinical trial</article-title>
<source/>Mol. Psychiatry
          <year>2018</year>
<pub-id pub-id-type="doi">10.1038/s41380-018-0097-2</pub-id>
</element-citation>
</ref>
<ref id="B91-cells-09-00062">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kosaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yamasue</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Inohara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Fujioka</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Anme</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Orisaka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ishitobi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin efficacy is modulated by dosage and oxytocin receptor genotype in young adults with high-functioning autism: A 24-week randomized clinical trial</article-title>
<source/>Transl. Psychiatry
          <year>2016</year>
<volume>6</volume>
<fpage>e872</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2016.152</pub-id>
<pub-id pub-id-type="pmid">27552585</pub-id>
</element-citation>
</ref>
<ref id="B92-cells-09-00062">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miura</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takeuch</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Anme</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nanba</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Adachi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tsubouchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sai</surname>
<given-names>Y.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Oxytocin for Male Subjects with Autism Spectrum Disorder and Comorbid Intellectual Disabilities: A Randomized Pilot Study</article-title>
<source/>Front. Psychiatry.
          <year>2016</year>
<volume>7</volume>
<fpage>2</fpage>
<pub-id pub-id-type="doi">10.3389/fpsyt.2016.00002</pub-id>
<pub-id pub-id-type="pmid">26834651</pub-id>
</element-citation>
</ref>
<ref id="B93-cells-09-00062">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parker</surname>
<given-names>K.J.</given-names>
</name>
<name>
<surname>Oztan</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Libove</surname>
<given-names>R.A.</given-names>
</name>
<name>
<surname>Sumiyoshi</surname>
<given-names>R.D.</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>L.P.</given-names>
</name>
<name>
<surname>Karhson</surname>
<given-names>D.S.</given-names>
</name>
<name>
<surname>Summers</surname>
<given-names>J.E.</given-names>
</name>
<name>
<surname>Hinman</surname>
<given-names>K.E.</given-names>
</name>
<name>
<surname>Motonaga</surname>
<given-names>K.S.</given-names>
</name>
<name>
<surname>Phillips</surname>
<given-names>J.M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2017</year>
<volume>114</volume>
<fpage>8119</fpage>
<lpage>8124</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1705521114</pub-id>
<pub-id pub-id-type="pmid">28696286</pub-id>
</element-citation>
</ref>
<ref id="B94-cells-09-00062">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kosaka</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yamasue</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yokoyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kikuchi</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Social Interaction Improved by Oxytocin in the Subclass of Autism with Comorbid Intellectual Disabilities</article-title>
<source/>Diseases
          <year>2019</year>
<volume>7</volume>
<elocation-id>24</elocation-id>
<pub-id pub-id-type="doi">10.3390/diseases7010024</pub-id>
</element-citation>
</ref>
<ref id="B95-cells-09-00062">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Higashida</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Furuhara</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamauchi</surname>
<given-names>A.M.</given-names>
</name>
<name>
<surname>Deguchi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Harashima</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Munesue</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lopatina</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Gerasimenko</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Salmina</surname>
<given-names>A.B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intestinal transepithelial permeability of oxytocin into the blood is dependent on the receptor for advanced glycation end products in mice</article-title>
<source/>Sci. Rep.
          <year>2017</year>
<volume>7</volume>
<fpage>7883</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-07949-4</pub-id>
<pub-id pub-id-type="pmid">28801574</pub-id>
</element-citation>
</ref>
<ref id="B96-cells-09-00062">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shindler</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Hill-Yardin</surname>
<given-names>E.L.</given-names>
</name>
<name>
<surname>Petrovski</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bishop</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Franks</surname>
<given-names>A.E.</given-names>
</name>
</person-group>
<article-title>Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism</article-title>
<source/>J. Autism Dev. Disord.
          <year>2019</year>
<pub-id pub-id-type="doi">10.1007/s10803-019-04231-6</pub-id>
</element-citation>
</ref>
<ref id="B97-cells-09-00062">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>H.C.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.J.</given-names>
</name>
</person-group>
<article-title>Resolving the topological enigma in Ca<sup>2+</sup>-signaling by cyclic ADP-ribose and NAADP</article-title>
<source/>J. Biol. Chem.
          <year>2019</year>
<volume>294</volume>
<fpage>19447</fpage>
<pub-id pub-id-type="doi">10.1074/jbc.REV119.009635</pub-id>
<pub-id pub-id-type="pmid">31836674</pub-id>
</element-citation>
</ref>
<ref id="B98-cells-09-00062">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Z.Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J.G.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A Cell-Permeant Mimetic of NMN Activates SARM1 to Produce Cyclic ADP-Ribose and Induce Non-apoptotic Cell Death</article-title>
<source/>iScience.
          <year>2019</year>
<volume>15</volume>
<fpage>452</fpage>
<lpage>466</lpage>
<pub-id pub-id-type="doi">10.1016/j.isci.2019.05.001</pub-id>
<pub-id pub-id-type="pmid">31128467</pub-id>
</element-citation>
</ref>
<ref id="B99-cells-09-00062">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>H.W.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>C.B.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Cambronne</surname>
<given-names>X.A.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Migaud</surname>
<given-names>M.E.</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>R.H.</given-names>
</name>
</person-group>
<article-title>Pharmacological bypass of NAD<sub>+</sub> salvage pathway protects neurons from chemotherapy-induced degeneration</article-title>
<source/>Proc. Natl. Acad. Sci. USA
          <year>2018</year>
<volume>115</volume>
<fpage>10654</fpage>
<lpage>10659</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1809392115</pub-id>
<pub-id pub-id-type="pmid">30257945</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="cells-09-00062-f001" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Cluster of differentiation 157 (CD157) expression analyzed by immunofluorescence staining in the embryonic mouse brain. Representative images were obtained from the E17 embryonic hypothalamus near the third ventricle (3V). CD157 is stained in green, nestin in red, and the nucleus in blue. Two merged images show the expression of CD157 in neural stem cells. Scale bar, 100 and 30 μm for the four left and enlarged images, respectively.</p>
</caption>
<graphic xlink:href="cells-09-00062-g001"></graphic>
</fig>
<fig id="cells-09-00062-f002" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Identification of Ca<sup>2+</sup>-calmodulin-dependent protein kinase II (CAMKIIβ) as the human CD38 (hCD38)-associated protein by MALDI-TOF. The domain structures of the canonical sequence of human CAMKIIβ (isoform-4: UniProtKB/Swiss-Prot, Q13554) are shown as squares in the middle. The kinase domain (14–272) is shown in blue. The regulatory tail (273–315), linker region/insertions, and the association domain (532–664) are also depicted. The corresponding portions of “Chain A, crystal structure of CAMKIIβ isoform 1” (CAMK IiB isoform 1) and isoform CRA_A are marked as blue and green bars, respectively. The numbers 1–3 and 4 indicate the domains of CAMKIIβ at which CD38 binds, and sequences of four tryptic peptides of CAMKIIβ identified by MALDI-TOF/MS, respectively.</p>
</caption>
<graphic xlink:href="cells-09-00062-g002"></graphic>
</fig>
<fig id="cells-09-00062-f003" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Effect of a CAMKII inhibitor on wound-induced migration facilitated by the expression of human influenza hemagglutinin (HA)-hCD38. (<bold>A</bold>,<bold>B</bold>) Human embryonic kidney 293T (HEK293T) cells grown on plastic dishes were transfected with <italic>HA-hCD38</italic> complementary DNA (cDNA) constructs. One day after transfection, a cell-free area was formed by scratching the plastic dishes, and they were treated with 0.1% dimethyl sulfoxide (DMSO) solution (control, A) or with 1 µM KN-62, a CaM kinase inhibitor, dissolved in 0.1% DMSO solution (<bold>B</bold>). At 24 h after scratching, they were fixed, permeabilized, and stained with HA monoclonal antibody (mAb). The right panels are merged images of fluorescent (Left) and phase-contrast (Middle) pictures. Scale bar, 100 µm. (<bold>C</bold>) Quantification of cell migration using the monolayer wound healing assay. The degree of migration was expressed as a reduction of the cell-free area by occupied cells. Each bar corresponds to 293T cells transfected with (green bars) or without (yellow bars) 1 µM of KN-62 (+KN). Each bar is the mean ± standard error of the mean (SEM) in seven experiments. Two-way ANOVA, <italic>F</italic><sub>3,7</sub> = 7.98, <italic>p</italic> = 0.0001. A significant difference was seen in the conditions of <italic>CD38</italic> transfection and KN treatment, but no significant interaction between transfection of <italic>CD38</italic> and treatment with KN-62 was observed (<italic>p</italic> = 0.18). Bonferroni’s post hoc analysis revealed a significant difference from the KN-free control value (*<italic>p</italic> &lt; 0.05).</p>
</caption>
<graphic xlink:href="cells-09-00062-g003"></graphic>
</fig>
<fig id="cells-09-00062-f004" orientation="portrait" position="float">
<label>Figure 4</label>
<caption>
<p>Hypotheses of CD38 and CaMKII interaction. Two models represent the possible means of activation of CaMKII by binding of calmodulin (CaM) and Ca<sup>2</sup><sup>+</sup> to the regulatory domain of CaMKII. Ca<sup>2</sup><sup>+</sup> is increased from ryanodine receptors bound by cyclic ADP-ribose (cADPR). cADPR is produced by either type II or type III CD38.</p>
</caption>
<graphic xlink:href="cells-09-00062-g004"></graphic>
</fig>
<fig id="cells-09-00062-f005" orientation="portrait" position="float">
<label>Figure 5</label>
<caption>
<p>Scheme of CD38- and CD157-mediated pathways related to social behavior. The scheme shows the possible molecular mechanisms for increases in brain oxytocin (OT). One is OT release due to CD38 and CD157. Another is owing to receptor for advanced glycation end-products (RAGE)-dependent transport of OT into the brain. CD38- and CD157-dependent social behaviors are listed. The increased OT may trigger prosocial behavior.</p>
</caption>
<graphic xlink:href="cells-09-00062-g005"></graphic>
</fig>
<fig id="cells-09-00062-f006" orientation="portrait" position="float">
<label>Figure 6</label>
<caption>
<p>Scheme of the recruitment of OT in the brain extracellular space. OT in the blood is transported by RAGE on the endothelial cells of the blood–brain barrier (BBB). The OT in oxytocinergic neurons is secreted into the extracellular space via CD38 or CD157 from dendrites and axon collaterals. At the axon terminals, OT is released into the portal vein at the posterior pituitary. The turnover of OT may be a basis of social behavior.</p>
</caption>
<graphic xlink:href="cells-09-00062-g006"></graphic>
</fig>
</floats-group>
</article>
</pmc-articleset>